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Abstract
Molecular simulations and modeling of HIV-1 gp41 membrane spanning domain
(MSD) in a model viral bilayer
Michelle Katherine Baker
Advisor: Cameron Abrams
HIV-1 envelope protein complexes known as “spikes” are trimers of gp120 and
gp41 that mediate fusion and infection to target cell membranes. The membrane
spanning domain (MSD) of gp41 contains several highly conserved residues important
for fusion, however the structure and function of MSD are only partly understood.
All-atom simulations can elucidate how the conserved residues affect MSD structure
to provide atomistic insight into HIV-1 fusion.
Extensive molecular dynamics (MD) of monomeric HIV-1 gp41 MSD in model
viral bilayers was used to investigate the conserved midspan arginine and the re-
quirement of cholesterol for fusion. All wild-type peptides were α-helical, remained
membrane-spanning, and solvated their midspan arginines with a water defect that
was independent of cholesterol. However, the simulations indicate that cholesterol
may allow the spike to localize the water defect and to control the tilt of the helices.
The dynamics of the model viral bilayer with∼50% cholesterol was explored with 3
systems and simulated for up to 10 µs to explore the phase space of configurations, an
order of magnitude greater than previous studies. This timescale allowed observation
of diffusive motion and calculated diffusion coefficients agreed with experiments.
Oligomeric forms of the MSD were then created to examine the GXXXG motif,
known for helical, transmembrane, dimer interactions, but conserved in the MSD
of the trimeric gp41. The lowest-energy trimeric MSD with interacting GXXXG
residues could not mediate trimerization in a bilayer on 100 ns timescales. However,
the lowest energy MSD dimer remained associated on similar timescales, suggesting
xvii
a dimer form of the MSD during fusion.
Finally, the trimeric MSD was stabilized by addition of the trimeric crystal struc-
ture of the gp41 membrane proximal external region (MPER). Simulation of the
MPER-MSD trimer for 11 µs showed relaxation towards a different, stable configura-
tion in which the GXXXG motifs were not interacting but the cholesterol recognition
motif (CRAC) sequestered water and cholesterol. This is the first simulation of a
model of trimeric MPER-MSD in a cholesterol-containing bilayer and it may rep-
resent a point between the prefusion and the prefusion intermediate experimental
trimeric structures.

11. Introduction
Since the discovery of acquired immunodeficiency syndrome (AIDS) in the early
1980s, much research has focused on the virus responsible, human immunodeficiency
virus (HIV-1), but there is still no vaccine or cure. In 2013, the Joint United Na-
tions Programme on HIV/AIDS (UNAIDS) reported that 35.3 million people are
currently infected with HIV. In 2012, there were 1.6 million AIDS-related deaths, a
29% decrease since 2005, and there were 2.3 million new infections, a 33% decrease
since 2001 [2]. The progress made by UNAIDS towards reducing the number of
new infections, current infections, and AIDS-related deaths is a direct result of im-
proved access and affordability of antiretroviral therapy (ART), which decreases viral
loads and transmission. Unfortunately, ART and highly active antiretroviral therapy
(HAART) are costly, have side effects, and are becoming less effective as the virus
gains resistance. Therefore, new insights leading to novel therapeutics are strongly
needed. Molecular details of the HIV-1 fusion and infection process are only partly
understood. Structures of the fusion proteins gp120 and gp41, known collectively as
“spike”, are only partial and do not contain enough information to model the entire
fusion process. In order to better understand the function of these proteins during
fusion, more complete, unliganded structures in a membrane context are necessary.
Structural investigations of spike are complicated because the fusion proteins are non-
covalently associated and gp120 holds gp41 in a metastable structure in the native,
unliganded spike. The gp41 protein mediates fusion of the viral and cellular mem-
branes and is also a target for drug design. Partial structures exist for the more stable,
soluble, postfusion gp41 six helix bundle (6HB) structure, but less is known about
the prefusion, membrane-associated structures. HIV-1 infection requires cholesterol,
however cholesterol in the viral membrane is not always accounted for in experiments.
2Computational simulations can augment experimental investigations into the HIV-1
fusion process and the structure/function relationships of the spike proteins. This
thesis will detail the use of all-atom molecular dynamics (MD) to characterize the
membrane-associated sections of the HIV-1 envelope protein gp41.
1.1 HIV-1 lifecycle
HIV-1 fusion is mediated by envelope glycoproteins gp120 and gp41, which exist
as a trimer of hetero-dimers or “spikes” on the viral membrane. HIV-1 particles have
∼10 spikes per particle, however it is not known if more than one spike is required for
fusion [3]. By binding to CD4 on target cell membranes, gp120 initiates conforma-
tional rearrangements of spike, leading to co-receptor binding and to exposure of gp41
into its “prehairpin intermediate” state. This state involves bridging of the viral and
cellular membranes; gp41’s N-terminal fusion protein (FP) contacts the target cell
membrane while gp41’s membrane spanning domain (MSD) still anchors gp41 in the
viral membrane. This prehairpin intermediate state rapidly folds into an extremely
stable fusion state, where the heptad repeats of gp41 are arranged in a six helix bun-
dle (6HB); it is thought that the formation of 6HB is the driving force for bringing
together the viral and cell membranes and for fusion of the two bilayers. Infection
occurs when the viral capsid containing the viral RNA enters the target cell through
the fusion pore. The viral RNA is reverse transcribed into DNA and incorporated into
a host chromosome. In order for production of new viral particles, the viral DNA
is transcribed into mRNA, which is translated in the cytoplasm. (The mRNA for
Env, the envelope proteins, is translated at the ER). Viral proteins are assembled at
cholesterol-enriched sections of the cellular membrane. Env, after proteolytic cleavage
of its precursor protein gp160, is incorporated into the cellular membrane also. The
assembling virion starts to bulge from the cell membrane, aided by the polyprotein
3Gag, and eventually buds off. As an enveloped virus, the HIV membrane is therefore
“stolen” directly from cholesterol-enriched sections of the cellular membrane. After
maturation, the mature viral particle is then ready to infect a new cell [4–7].
1.2 Importance of cholesterol in the HIV-1 lifecycle
The HIV-1 membrane is highly enriched in cholesterol, up to 45%, because it
buds from microdomains in the cell membrane enriched in cholesterol [8]. A large
amount of cholesterol in the viral membrane is required for infection. If cholesterol
is extracted from the membrane using β-cyclodextrin (βCD), infectivity is abolished.
Infectivity is quickly reestablished if the membrane is incubated with cholesterol-
loaded βCD [9, 10]. Cholesterol also plays a role in other parts of the HIV-1 lifecycle,
such as budding and co-receptor binding, but it is not known which properties of
cholesterol are necessary for fusion [6, 11–15]. It is known that cholesterol increases
the order and decreases the fluidity of bilayers [16]. Another possible mechanism
of HIV-1 infection, compared to virus-cell membrane fusion, is the idea that the
mature virion is osmotically stressed and that pressure on the spike can “pop” the
virus, allowing the RNA-containing capsid to enter the cell membrane [17]. A stiff
membrane, from a high amount of cholesterol, could relate to this idea of metastability
of the spike and membrane.
1.3 Experimental structures of the spike
3D structure as determined by cryoelectron microscopy (cryo-EM) of the unli-
ganded HIV or SIV spike shows a hollow cage-like ectodomain with either tripod or
stalk membrane-adjacent structure for gp41 [18–20]. Partial structures of gp120 and
gp41 have also been determined using X-ray crystallography and NMR [21–27]. The
parts of spike that interact with the membrane are less known. A recent cryo-EM
4structure of the uncleaved, unliganded HIV-1 spike includes part of the gp41 MSD as
a left-handed α-helical coiled-coil with a crossing angle of 35◦ [28].
1.4 Segments of HIV-1 gp41
Dual functions for gp41 include anchoring the spike in the membrane and playing
a role in fusion. The native structure of gp41 is unknown and it is postulated to be
hidden and held in a metastable state by gp120. A “map” of the different sections of
gp41 are shown below: starting from the N-terminal, FP is fusion peptide, FPPR is
N- FP - FPPR - NHR - loop - CHR - MPER - MSD - CT -C
fusion peptide proximal region, NHR is N-terminal heptad repeat, CHR is C-terminal
heptad repeat, MPER is membrane proximal external region, MSD is membrane
spanning domain, and CT is cytoplasmic tail. During fusion, the FP inserts into
the target cell membrane and plays a role in perturbing the cell bilayer. It can
adopt multiple membrane-associated structures, as it is conformationally flexible and
seems to be highly influenced by its environment [29, 30]. The cholesterol content
of the target cell membrane determines whether FP adopts an α-helical or β-sheeted
structure [31]. The postfusion, soluble 6HB, composed of the heptad repeat sections
NHR and CHR, has been characterized as an α-helical coiled-coil [21]. The 6HB has
also been crystallized with extensions of FPPR and MPER [26]. Structures for MPER
and MSD are discussed in the sections below. The CT contains a highly immunogenic
region (HIR) and 3 α-helical lentiviral lytic peptides (LLP1, LLP2, and LLP3) that
bind to the membrane on the endoplasmic side (inner leaflet). Interestingly, CT
5is required for Env incorporation and fusion only in certain cell types (known as
nonpermissive cell lines) [32].
1.4.1 HIV-1 gp41 MPER
Table 1.1: HIV-1 gp41 MPER peptide sequence
sequence E L D K W A S L W N W F N I T N W L W Y I K
residue index 660 . 662 . 664 . 666 . 668 . 670 . 672 . 674 . 676 . 678 . 680 .
Figure 1.1: Representative MPER configuration with residues of interest highlighted: tryptophans
in blue (W664, W668, W670, W676), CRAC domain in yellow (L677, W678, Y679, I680, K681),
and CRAC tryptophan in green (W678).
MPER is important for partitioning of spike into cholesterol-rich domains before
budding and for membrane perturbation during fusion. It has many highly conserved
6residues, such as five tryptophan residues and a cholesterol-sequestering CRAC motif
(LWYIK). The sequence of 22 residues that constitute MPER is shown in Table 1.1,
with the CRAC residues in bold, and important residues are highlighted in Figure 1.1.
Since MPER contains epitopes for the most broadly neutralizing antibodies against
HIV-1, it has been a prime target for drug and vaccine design [33, 34]. However, the
epitopes of MPER are only briefly exposed during fusion [25, 33, 35, 36]. Studies of
full-length MPER, partial-length MPER, and CRAC domain peptides have revealed it
has a high flexibility in a variety of environments (membrane prone, transmembrane,
soluble) and has the ability to disrupt bilayers [23, 24, 37–43].
1.4.2 HIV-1 gp41 MSD
The membrane spanning domain (MSD) of gp41 is also dual-functional. Besides
anchoring the spike, it has a specific sequence that is important for fusion. The func-
tional importance of the specific sequence of the MSD is illustrated by experiments
where replacement of the HIV-1 gp41 MSD with the MSD of the vesicular stomatitis
virus G protein or influenza hemagglutinin glycoprotein abolished fusion to CD4+
HeLA or Jurkat T cells despite normal processing and expression [44, 45]. MSD has
the most highly conserved residues important for HIV-1 infection, such as charged
residues K681, R694, R705, R707, and the GXXXG motif, postulated to mediate
transmembrane dimer interactions (see Table 1.2 and Figure 1.2). It is unknown if
the GXXXG motif acts as a trimerization motif for the MSD, since gp41 is a trimer.
Like other lentiviral MSDs, the HIV-1 MSD has a highly conserved midspan arginine,
which places a positively charged residue in a hydrophobic bilayer [44, 46–48]. The
single mutation of the conserved midspan arginine to leucine (R694L) was shown to
have normal surface expression but diminished fusion activity [44, 49]. Mutations of
the other conserved motifs showed similar consequences [46, 50–54]. It is not known
7how the viral membrane accommodates a charged midspan arginine (R694) or why
it is important for fusion. A “snorkeling model” has been proposed for the MSD,
which would allow the midspan arginine to interact with negatively charged lipid
headgroups [1, 47, 55]. Water defects have been observed in similar membrane sys-
tems with a charge, but the presence of a water defect has not been established in
the HIV-1 gp41 MSD [56–64].
Table 1.2: HIV-1 gp41 MSD peptide sequence
sequence K L F I M I V G G L V G L R I V F A V L S I V N R V R
residue index 681 . . 684 . . 687 . . 690 . . . 694 . . . 698 . . 701 . . 704 . . 707
local index 1 . . 4 . . 7 . . 10 . . . 14 . . . 18 . . 21 . . 24 . . 27
Figure 1.2: Representative MSD configuration with residues of interest highlighted: from left to
right, lysine 681 in pink (L681), glycines in GXXXG motif in green (G688, G689, G692, first X is
glycine), XX residues in GXXXG motif in yellow (L690, V691), midspan arginine in white (R694),
and C-terminal arginines in blue (R705, R707).
8Bioinformatic studies and circular dichroism (CD) analysis predict the MSD to be
α-helical and mutagenesis experiments support that the MSD is membrane-spanning
[54, 65–67]. However, there are no crystal or NMR structures of gp41 MSD yet, so
it is difficult to understand the functional importance of the conserved residues. In
general, membrane proteins such as gp41, are extremely difficult to experimentally
determine the structure (by crystallography or NMR) and are underrepresented in
the Protein Data Bank [68]. However, investigations into the structure of HIV-1 gp41
MSD in a model viral bilayer are appropriate for molecular simulations. This thesis
details a segment-based approach to gp41 MSD structure determination using all-
atom molecular dynamics. The structural narrative of gp41, especially the membrane
spanning domain, is a key component to HIV-1 fusion and infection.
1.5 Aims of thesis
1.5.1 Aim I: HIV-1 gp41 MSD midspan arginine solvation
In order to construct a computational model of the HIV-1 spike in a cholesterol-
containing membrane, segments of gp120 and gp41 can be individually studied and
then combined together. In a first step towards building a native trimeric gp41,
the monomeric MSD peptide in a model viral membrane was studied to elucidate
the solvation of the midspan arginine and the potential influence of cholesterol on
solvation.
1.5.2 Aim II: Dynamics of HIV-1 model viral membranes with cholesterol
Cholesterol plays many important roles in the HIV-1 lifecycle but it is not known
which properties of cholesterol are important for fusion. The MSD of gp41 directly
interacts with the viral membrane and a comprehensive study of the MSD must
examine interactions with cholesterol and lipids. The dynamics of the model bilayer
9simulated in Aim I were ascertained in Aim II. The composition of the model bilayer
with cholesterol was evaluated for stability and relevance to HIV-1 infection.
1.5.3 Aim III: Modeling of HIV-1 gp41 MPER-MSD trimer in a choles-
terol containing bilayer
The information obtained in Aims I and II was applied to construct a model of
trimeric MSD in a cholesterol-containing bilayer. In Aim III, trimeric MSD mod-
els were enumerated in vacuum and the lowest energy structure was equilibrated in
membrane. Trimeric MPER was augmented to the model and simulated on the µs
timescale in order to see relaxation of the trimeric MPER-MSD model to a different
configuration.
1.5.4 Aim IV: Role of the dimerization motif, GXXXG, in the MSD of
trimeric HIV-1 gp41
Although it has been postulated that the conserved transmembrane dimerization
GXXXG motif in MSD is responsible for MSD or gp41 trimerization, the motif dis-
associated in the 150 ns MSD trimer simulation and the 11 µs MPER-MSD trimer
simulation in Aim III. Aim IV simulated the MSD dimer on the 100 ns timescale
to identify possible reasons for trimeric disengagement in Aim III and to assess the
validity of GXXXG as a trimerization motif for MSD.
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2. Computational Methods
2.1 Molecular Dynamics
Molecular dynamics (MD) is a simulation technique based on classical mechanics
where, given initial atomic positions and their potential, velocities and positions at
the next point in time can be calculated. Repeating the calculation multiple times
generates a trajectory, on the scale of ps to µs. The potential, in the form of a “force
field”, represents several interactions, including those of bonds, angles, dihedrals, van
der Waals, and electrostatics. The integrator chosen for the calculations must provide
the correct ensemble distribution, as dictated by statistical mechanics. For statistical
mechanics theory and the principles of molecular dynamics, the reader is referred to
references [69–72].
2.2 Protocols
All-atom MD simulations were performed with NAMD 2.8 and 2.9 [73] along
with VMD 1.9 [74], the CHARMM force field [75, 76] with recent lipid-based correc-
tions [77–79], and explicit TIP3P water. Unless noted, all systems were run in the
NPT ensemble with a temperature of 310 K (body temperature) and a pressure of 1
atm. The NPT ensemble (constant number of atoms, pressure, and temperature) was
simulated with Langevin dynamics with a coupling constant of 5 ps−1 for tempera-
ture control and with the Langevin Nose´-Hoover method for pressure control [80, 81].
The pressure was treated isotropically as fluctuations in x and y (corresponding to
membrane lateral area) are uncoupled to fluctuations in the z direction in membrane
simulations. Electrostatics were accounted for by the particle-mesh Ewald (PME)
method [82] for systems with periodic boundary conditions with a grid spacing of
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either 1 or 2 A˚. Verlet integration was applied every 1 or 2 fs. Nonbonded forces were
shifted off from either 8 to 9 A˚ or 10 to 12 A˚.
2.3 Previous Group Work
Previously, the initial coordinates for gp41 MSD were created by starting with an
NMR structure of a 27 amino acid α-helical subdomain of HIV-1 Vpu protein from
the Protein Data Bank [83]. Using those initial positions for the backbone, the side
chains of Vpu were removed and the side chains of HIV-1 gp41 MSD were added
using VMD. The peptide was solvated, neutralized, ionized to a strength of 0.1 M
(Na+ and Cl−), and equilibrated (100 ps NPT, 20 ns NVT) before being pulled into
a 512-lipid membrane using constant velocity steered molecular dynamics (SMD), as
rendered in Figure 2.1. Two different conformations were created by pulling either
the N- or C-terminus, leading to an endoplasmic snorkeling R694 and an exoplasmic
snorkeling R694, respectively. The initial membrane coordinates were created with
the CHARMM-GUI membrane builder and contained 50% dipalmitoylphosphatidyl-
choline (DPPC) and 50% cholesterol by mol [84]. The membrane was solvated with
explicit TIP3P waters, neutralized, ionized, and equilibrated for 6 ns NPT MD before
the addition of the peptide. During SMD, the lipid headgroups were restrained in
the z-direction and the steering velocity was 10 A˚/ns. For the exoplasmic snorke-
ling model, the SMD atom was the center of mass of R707. For the endoplasmic
snorkeling model, the SMD atom was the center of mass of K681 and the secondary
structure was restrained. The peptide-membrane system was cut to a smaller size,
neutralized, ionized to 0.1 M, and equilibrated for 5 ns NVT MD [85]. The resulting
system contained 151 lipids and 183 cholesterol molecules (resulting in a membrane
composition of 45.2% DPPC and 54.8% cholesterol) and was then used to initiate
both long production MD and metadynamics simulations.
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Figure 2.1: Initial configuration for SMD. Lipids are in silver vdW, cholesterol in blue vdW, protein
in white vdW, and water in cyan isosurface. No hydrogen atoms are shown for simplification.
2.4 Choice of Lipids
The MSD peptide was embedded in a bilayer composed of ∼50% cholesterol and
∼50% DPPC, which represents a model of the HIV-1 viral membrane. Since new
HIV-1 particles bud from sections of the cell membrane high in cholesterol, the HIV-
1 bilayer is about 50% cholesterol [8]. Another major component of the viral bilayer is
sphingomyelin (SM). However, the force field utilized in these simulations, CHARMM,
did not have any parameters for SM in the open literature. (However, one month af-
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ter my defense, CHARMM parameters for sphingomyelin were published [86].) A
common computational and experimental substitute is DPPC. Both DPPC and SM
are fully saturated lipids and undergo their main phase transition around the same
temperature [87, 88]. Importantly, there exist CHARMM parameters for DPPC.
Therefore, the binary model of ∼50% DPPC and ∼50% cholesterol is an acceptable,
but simple, model of the HIV membrane. At the physiological temperature of 310
K, this binary model will be liquid ordered [89, 90], which is confirmed by lipid or-
der parameters discussed in Chapter 3. The model used here of a cholesterol-free
virus is 100% DPPC. There does not exist in literature, to the best of our knowl-
edge, a measurement using MD of the DPPC phase transition temperature with the
CHARMM36 force field, but other force fields calculate Tm to be between 300 and
320 K [91, 92]. This compares fairly well to experimental measurements of 314-315
K [93, 94]. Indeed, the pure DPPC bilayers simulated here are gel-like and, according
to lipid order parameters, are slightly less ordered than the cholesterol-free bilayers
(see Chapter 3).
2.5 Benchmark Parameters
Benchmark parameters for several representative systems are located in Table 2.1.
2.6 Trajectory Analysis
The trajectories were analyzed with codes/scripts in c, tcl, and MATLAB. (See
Appendices A and B for examples in tcl.) Figures were either rendered in VMD [74]
or created using gnuplot or GIMP.
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Table 2.1: Benchmark parameters for eight representative simulations
System
Simulation # of
MD parameters
Version of MD
Supercomputer # Cores ns/day
cores x time
Time atoms Software per step (s)
WT1 300 ns 58,185 1 fs, PME 2.0, nb 8 to 9 A˚ NAMD 2.8b1 Lonestar 192 42.7 0.4
WT2 300 ns 59,288 1 fs, PME 2.0, nb 8 to 9 A˚ NAMD 2.8b1 Lonestar 192 41.0 0.4
WT1c 100 ns 58,185 2 fs, PME 1.0,nb 10 to 12 A˚ NAMD 2.9 Stampede 96 15.5 1.1
WT2∆Chol 300 ns 89,017 2 fs, PME 1.0,nb 10 to 12 A˚ NAMD 2.9 Stampede 96 10.4 1.6
R694L Metadynamics 320 ns 57,948 1 fs, PME 1.0, nb 8 to 9 A˚ NAMD 2.8b1 Ranger 96 15.7 1.1
MSD+MPER trimer 133 ns 97,825 2 fs, PME 1.0,nb 10 to 12 A˚ NAMD 2.9 Stampede 96 9.1 1.8
WT2 8 µs 59,381 2 fs, see Appendix C Anton 2.6.4 Anton 512 3588 2.5e-11
MSD+MPER trimer 12 µs 97,825 2 fs, see Appendix C Anton 2.12.4 Anton 512 3707 2.4e-11
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3. Aim I: HIV-1 gp41 MSD midspan arginine solvation
3.1 Introduction to Aim I
The membrane spanning domain (MSD) of HIV-1 gp41 anchors the fusion complex
known as “spike” in the viral membrane. It has a specific amino acid sequence that is
highly conserved and is important for fusion/infection. For instance, the positively-
charged midspan arginine (R694, residue 14 of 27) exists in 98% of sequences in
the Los Alamos HIV-1 database [95] and mutations of the arginine negatively im-
pact fusion [49]. Since the MSD is postulated to be helical and to span the bilayer
once, this potentially places R694 in the middle of a hydrophobic environment. A
“snorkeling” model has been proposed in which R694 can access lipid headgroups and
water [1, 47, 55], perhaps creating a “water defect”. Water defects have been observed
in both simulations and NMR experiments on charges in a hydrophobic environment,
such as guanidinium ions, arginine analogs, and transmembrane proteins with argi-
nine(s) in a lipid bilayer [56–64]. In fact, the free energy of insertion of an arginine
in a bilayer has been calculated to be a few kcal/mol with solvation [59, 96, 97]. It
is reasonable to think that R694 of MSD can cause water ingress, although it has
not been previously studied. Therefore, in Aim I we considered whether MSD had a
water defect, considered how such a defect depended on the membrane composition,
and speculated on the role of such a defect in the fusion process. Also, the HIV-1
viral membrane has a high cholesterol content; cholesterol seems to have multiple
roles in the HIV-1 lifecycle and cholesterol depletion from the virion compromises
fusion [8, 11, 13]. Starting with a model of the monomeric MSD in a cholesterol-
containing bilayer, we characterized the equilibrium properties of MSD on a 300 ns
timescale using all-atom molecular dynamics (MD). We utilized multiple replicas,
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target mutations, protein-free membranes, cholesterol-containing and cholesterol-free
membranes, and 3.4 µs total simulation time to systematically describe in detail the
protein and membrane properties of the system. (See Figure 3.1 for some represen-
tative systems.) We aimed to answer the following questions:
1. What mechanism allows for the midspan arginine to compensate for its charge
and how does this affect the MSD configuration?
2. How does the presence or absence of cholesterol affect the MSD configuration?
3. Does cholesterol influence the midspan arginine solvation?
3.2 Methods
3.2.1 System setup
The initial all-atom system consisted of the 27-residue MSD peptide in a bilayer
(composed of ∼50% dipalmitoylphosphatidylcholine (DPPC) and ∼50% cholesterol)
with explicit water and ions; this system was known as WT1. Two more replicas
were created by pulling the MSD peptide with constant velocity SMD into different
locations in the initial model bilayer, resulting in different local lipid arrangements
around the MSD (see Appendix Figure 3.14). These systems with different initial
conditions were referred to as WT2 and WT3 and were equilibrated for 6 ns NPT
MD and 1 ns NVT MD before being subjected to equilibrium sampling. In order to
investigate the importance of the midspan arginine, R694 in the WT1 system was
mutated to leucine by using the Mutator plugin in VMD. Leucine is a hydrophobic
residue that should not be solvated. This mutant system was referred to as the R694L
system and after mutation, was further equilibrated for 3 ns in the NPT ensemble
and then run for 5 ns in the NVT ensemble. To remove any initial condition bias
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Figure 3.1: Representative system configurations from equilibrium MD at 300 ns rendered in VMD
for the WT1, R694L, WT1∆Chol, and WT3∆Chol systems: lipid headgroups are in red, lipid tails in
white, cholesterol in yellow, water in cyan, peptide in orange, and R694 or R694L in orange spheres.
Water with oxygens within 4 A˚ of the protein and located on the inner leaflet of the membrane
are shown in cyan spheres. For clarity, lipids, cholesterol, and water in the foreground of all four
configurations are not shown.
associated with pulling the WT peptide into the membrane, the leucine was mutated
back to arginine (R694LR) after the R694L system was simulated for 300 ns. In
order to investigate the importance of cholesterol, the MSD peptide was also pulled
into a pure DPPC bilayer using constant velocity SMD and equilibrated, resulting
in the WT1∆Chol system. Two more replicas were also created (WT2∆Chol and
WT3∆Chol); the WT1∆Chol system was branched off at pre-equilibration and 0
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ns, the protein backbone was constrained, and the systems were simulated for 25 ns
NPT MD to allow further equilibration of lipids and water around the proteins be-
fore production MD. Protein-free systems were referred to as DPPC and DPPC/Chol
systems. For production runs, all systems were simulated for 300 ns NPT MD. The
cholesterol-containing systems had ∼58,000 atoms, including 183 cholesterol and 151
DPPC molecules. These systems were roughly 80 x 80 x 80 A˚3. The pure DPPC sys-
tems had ∼89,000 atoms, including 334 lipid molecules. These systems were roughly
90 x 90 x 100 A˚3. A few of the systems (WT1, R694L, WT1∆Chol, and WT3∆Chol)
are shown in Figure 3.1.
3.2.2 Comparison of parameters on accuracy and performance
The initial systems WT1 and WT1∆Chol were first simulated for 100 ns with
different MD parameters to assess computational time and accuracy. The first set of
parameters were based on those recommended by CHARMM-GUI Membrane Builder
(grid spacing of 1 A˚, 2 fs timestep, nonbonded shifted from 10 to 12 A˚) [84]. The
second set was more aggressive (grid spacing of 2 A˚, 1 fs timestep, nonbonded shifted
from 8 to 9 A˚). For the cholesterol-containing systems, both the CHARMM-GUI-
recommended and more aggressive parameters resulted in negligible differences in
observables for the two systems (WT1c and WT1, respectively) as seen in Appendix
Figure 3.15. Therefore, all cholesterol-containing systems were run with the second
set of parameters for the slightly lower computational time. However, the cholesterol-
free systems had to be run with the first set of parameters to maintain accuracy of
certain observables. See Table 2.1 for benchmark parameters for WT1 and WT1c.
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3.2.3 Metadynamics
The conformational space of the model of the WT MSD in a bilayer was previously
sampled to assess the stable state for equilibrium MD [1]. In order to sample the
conformational space of the mutant peptide, metadynamics was used to accelerate
rare conformational events and construct the free energy profile along a particular
CV. In metadynamics, the MD trajectory is biased by a history-dependent potential
that is the sum of Gaussians deposited along the CV; the forces arising from these
Gaussians allow high-probability regions along CV space to be explored first and
discourage the system from revisiting the same CV values [98–101]. From Laio et al.,
the external potential is defined as
Vmeta(ξ) =
t′<t∑
t′
W
Ncv∏
i=1
exp
{
−
[ξi − ξi(t
′)]2
2δ2ξi
}
, (3.1)
where ξi is the value of CV, ξi(t
′) is the value of ξi at time t
′ from the atomic co-
ordinates, W is the Gaussian height, δξ is the Gaussian width, and t
′ values are the
frequency in MD steps with which Gaussians are deposited. The R694L system was
started from the NVT equilibrated, mutated system and run for 320 ns of constant-
NVT metadynamics, after indication that the system had become diffusive, with a
timestep of 2.0 fs and all hydrogen bonds constrained by SHAKE [102]. The CV was
defined as the RMSD of the backbone atoms (C, Cα, N, O) of the peptide with respect
to a perfect α-helix, an average over a total of 109 atoms. The lower boundary, an
RMSD of 0 A˚, indicated a perfect helix, and the upper boundary, an RMSD of 10 A˚,
indicated a partially unfolded peptide. The parameters included a Gaussian width of
0.01 A˚, a weight of 0.15 kcal/mol, and a deposition frequency of 1 ps. Standard MD
was continued after 300 (CV of 4.8 A˚) and 304 ns (CV of 8.7 A˚) of metadynamics for
20 and 37 ns, respectively, in the NVT ensemble to confirm the stable state.
20
3.2.4 Calculations of observables
The mass density of water (within 4 A˚ of protein and global), lipid headgroups,
lipid tails, cholesterol, protein, and midspan residue in amu/A˚3 along membrane
normal from the last 100 ns was calculated by first rewrapping the trajectories in x
and y by using the peptide center of mass and then in z by using the bilayer center
of mass. Statistics for WT include systems WT1, WT2, and WT3 and statistics
for WT∆Chol include WT1∆Chol, WT2∆Chol, and WT3∆Chol. Local density of
lipid headgroups, lipid tails, and cholesterol (within 6 A˚ of protein) in amu/A˚3 along
membrane normal was also calculated from the full 300 ns trajectory. The tilt of
the helix was determined by measuring the angle between membrane normal (z-axis)
and a vector aligned along the helix. The number of unique water molecules within
4 A˚ of the protein was attributed to the closest residue (Appendix A). To create 2D
membrane thickness maps, the bilayer was sectioned into 4 x 4 A˚2 patches and the
difference between the centers of mass of the lipid headgroups in each leaflet was
attributed to a patch. In the lower leaflet, the average minimum water distance from
the bilayer interface was calculated for each 4 x 4 A˚2 patch to create the 2D water
penetration maps. Lipid order parameters, SCD, for each DPPC tail were calculated
from
SCD = 〈
3 cos2 θ − 1
2
〉, (3.2)
where θ is the angle between the carbon-hydrogen vector in a lipid acyl chain and
bilayer normal [103]. Hydrogen bonds were calculated using a donor-acceptor cutoff
of 3.5 A˚ and an acceptor-donor-H cutoff of 30◦ [61].
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Figure 3.2: Unit cell area in nm2 vs simulation time in ns for A) cholesterol-containing systems
WT1, WT2, WT3, WT1c and B) cholesterol-free systems WT1∆Chol, WT2∆Chol, andWT3∆Chol.
3.3 Aim I results
3.3.1 Model membranes were stable during 300 ns MD
Both the cholesterol-containing and cholesterol-free membranes were stable on the
300 ns timescale and had properties that were consistent with previous experimental
and computational measurements. Figure 3.2 shows the unit cell area in nm2 dur-
ing the trajectories of several systems. The cholesterol-containing systems in Panel
A equilibrated quickly and had a stable unit cell area of around 70 nm2. Also, the
WT1c run with different simulation parameters as discussed in Methods had a similar
area to the production WT systems. In Panel B, the cholesterol-free systems required
over 100 ns to equilibrate to a stable area of around 83 nm2. Apparently, the initial
membrane configurations were not stable and needed over 100 ns to reach a more
stable state. However, the average area per lipid for the DPPC system after 300 ns,
48.8 A˚2, compared fairly well with the gel-phase experimental value of 47.2 A˚2 [104].
The area per lipid for the systems in Panel A is not trivial to calculate since the
systems contained two lipid components and a protein. However, other parameters
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like thickness, discussed in Section 3.3.5, and lipid order parameters, discussed be-
low, were consistent with previous experiments on model membranes with the same
composition.
The lipid order parameters, SCD, for both model membranes also supported that
the models were stable and consistent with liquid ordered (for cholesterol-containing)
or gel (cholesterol-free) bilayers [91, 105]. As seen in Appendix Figure 3.16 A and
B, the cholesterol-containing systems had high order parameters, which indicate that
they are very ordered.
3.3.2 Conformational sampling of HIV-1 gp41 MSD mutant with meta-
dynamics
The single mutation of the conserved midspan arginine to leucine (R694L) was
shown experimentally to have normal surface expression but diminished fusion ac-
tivity [44, 49]. Differences in system equilibrium properties (such as mass density,
peptide tilt, membrane thickness, and water organization) between the WT and
fusion/infection-diminished R694L MSD systems can highlight peptide properties or
molecular interactions that are favorable for viral membrane fusion and infection. The
effect of this mutation on the peptide structure and on the membrane environment
is not known as no experimental results on this question exist, to our knowledge.
Although it is not likely that the single mutation significantly changed the secondary
structure of the R694L MSD, it was still investigated for comparison to the previous
study on the WT MSD [1]. Conformational sampling of proteins using MD is limited
because accessible computation times do not permit rapid and repeated crossing of
free energy barriers in conformational space; therefore enhanced sampling methods
that invoke low-dimensional collective variables (CVs) and restricted free energies
are often advantageous. So, in order to confirm that the R694L MSD was also α-
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helical, metadynamics was conducted on the R694L MSD in a ∼50% DPPC and
∼50% cholesterol bilayer. This technique allowed us to reconstruct the potential of
mean force (PMF) along a conformational collective variable (CV), the RMSD of the
peptide backbone as compared to a perfect helix, and to then determine the stable
state [98–101].
Figure 3.3: Collective variable (RMSD of backbone compared to perfect helix) in A˚ vs simulation
time in ns for R694L peptide metadynamics. As insets are snapshots from along the R694L peptide
metadynamics trajectory rendered in VMD: R694L peptide in cyan new cartoon and R694L residue
in cyan vdW.
Metadynamics successfully explored the conformational space of the R694L MSD
in 320 ns, at which point the CV became diffusive over the CV range explored (Fig-
ure 3.3) and the cumulative potential of mean forces (PMFs) of the last 20 ns con-
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Figure 3.4: A, B) Convergence of cumulative PMFs for R694L peptide metadynamics. Con-
formational potential of mean force (PMF) in kcal/mol vs collective variable (RMSD of backbone
compared to perfect helix) in A˚ during A) 280 to 300 ns and B) 300 to 320 ns. C) Final cumulative,
conformational potential of mean force (PMF) in kcal/mol vs collective variable in A˚ from the R694L
peptide metadynamics, in black. The PMF vs CV from the WT1 peptide metadynamics from our
previous study is also shown here, in red diamonds [1]. Error bars represent standard deviations of
the last 20 ns.
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verged over the CV (Figure 3.4). The backbone RMSD of the peptide as compared
to a perfect helix seemed an appropriate CV choice for a small (27-residue) mem-
brane spanning α-helix because multiple refolding events were observed, as shown
in Figure 3.3. During the entire metadynamics trajectory, the R694L peptide re-
entered helical conformations during four separate events. Snapshots chosen from the
trajectory are shown as insets in Figure 3.3. The cumulative PMF versus CV was
averaged over 20 ns increments to assess convergence and the final PMF represented
the average of the last 20 ns of cumulative PMFs. Figure 3.4 shows the convergence
of the PMF during 280-300 ns and 300-320 ns. The cumulative PMF averaged from
the last 20 ns for the WT and mutant peptides is shown in Figure 3.4 C. The R694L
MSD PMF indicated a stable state with a low RMSD (≤ 2 A˚) and a metastable state
with an RMSD in the range 4 to 6 A˚. This is similar to the final PMF for the WT
system, with a slight difference in the CV value of the metastable state. As expected,
the R694L MSD did not have an appreciably altered stable state compared to the
WT MSD and the R694L system was used for running equilibrium MD of the helical
state.
To confirm that the stable state determined by metadynamics is the lowest free
energy minimum for the R694L peptide, standard MD was continued from 300 ns
of metadynamics and 304 ns of metadynamics, with starting CVs of 4.8 and 8.7 A˚,
respectively. Both of these trajectories rapidly refolded into stable α-helices in a few
ns, as shown in Figure 3.5. Clearly, these trajectories did not start in equilibrium
configurations and rapidly progressed through lower and lower energy configurations
until reaching the lowest free energy well. This behavior was fully consistent with the
PMF generated using metadynamics. Therefore, long NPT MD (300 ns) was next
performed for the WT systems with the peptides in the energetically preferred α-
helical state to allow determination of membrane and peptide equilibrium properties.
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Figure 3.5: Standard molecular dynamics started from the metadynamics trajectory for R694L.
Collective variable (RMSD of backbone compared to perfect helix) in A˚ vs simulation time in ns.
MD started after 300 ns metadynamics in black and 304 ns metadynamics in red.
3.3.3 Model of HIV-1 gp41 MSD was stable as a membrane-spanning
α-helix
The 300 ns production NPT MD simulations also support the conclusion that the
α-helical state was stable for both the WT1 and R694L systems. In Figure 3.6 A and
B, we show traces of the metadynamics CV observed during equilibrium MD launched
from helical initial states for both systems, along with CV histograms. Both systems
remained close to perfectly α-helical. The WT1 peptide seemed to have greater
flexibility than the R694L peptide, as indicated by its wider RMSD distribution. In
Figure 3.6 C, we show similar data for the WT1∆Chol system, which indicates that
the WT peptide was also helical in a pure DPPC membrane. The absence or presence
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of cholesterol seems to not have had an effect on the secondary structure of the MSD.
Similar RMSD values were observed for the WT2, WT3, R694LR, WT2∆Chol, and
WT3∆Chol systems (data not shown).
Figure 3.6: Collective variable (RMSD of backbone compared to perfect helix) in A˚ vs simulation
time in ns and histogram of RMSD vs frequency for equilibrium MD of A) WT1, B) R694L, and C)
WT1∆Chol systems.
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Equilibrium MD further shows that these stable α-helices remained membrane-
spanning. In Figure 3.7, we show mass-density profiles, averaged over the entire pro-
duction phase, for various components in the WT (averaged over 3 replicas), R694L,
and WT∆Chol (averaged over 3 replicas) systems. The right-hand panels in this
figure show global density profiles that establish the z-span (membrane normal) of
the bilayer, and the accompanying left-hand panels show the scaled local density of
protein and water within 4 A˚ of the protein. Clearly all proteins spanned the bilayer.
Also highlighted in the left-hand panels of Figure 3.7 are the mass density distribution
of atoms in the 694 residue; we see that R694 density overlaps with water density
within 4 A˚, indicating the R694 was solvated in both the WT and WT∆Chol systems.
R694L was not solvated, as expected. Mass density profiles for other systems are in
Appendix Figure 3.17.
3.3.4 Midspan arginine of MSD was solvated by a robust water defect
All systems with the wild-type sequence showed a solvated midspan arginine and
this was further quantified by finding the number of water molecules (within 4 A˚ of
the protein) uniquely associated with each residue, as seen in Figure 3.8. Panel A
shows the number of unique water molecules per residue for the WT1, WT2, and WT3
systems. The N- and C- termini were highly solvated, as they interacted with the lipid
headgroup region. The midspan arginine (local residue 14) interacted with 4.8 ± 0.03
(SE) water molecules in the WT1, WT2, and WT3 systems. This resulted in solvation
along the same side of the helices as the midspan arginine, which corresponds in the
figure to the solvation in the C-terminus every few residues (local residues 17, 21, 25).
As expected, the R694L system did not have any water molecules that solvated the
R694L residue, as seen in Panel B. After the setup of the R694L system with mutation
of residue 694 to leucine (see System Setup), the water molecules surrounding residues
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Figure 3.7: A, C, E) Mass density in 102 amu/A˚3 along membrane normal in A˚ during equilibrium
MD for various components of the system: protein, local water (defined as within 4 A˚ of protein), and
midspan residue (arginine or leucine). B, D, F) Mass density in amu/A˚3 along membrane normal
in A˚ during equilibrium MD for various components of the system: lipid tails, lipid headgroups,
water, and cholesterol. A) and B) are averages for WT1, WT2, and WT3 systems. E) and F) are
averages for WT1∆Chol, WT2∆Chol, and WT3∆Chol systems. All statistics are from the last 100
ns of each trajectory and error bars in A, B, E and F represent standard error.
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R694L to L700 took a mere 6 ns or less to vacate the membrane. The water molecules
did not return to these residues during 300 ns MD. To check initial condition bias of
the midspan arginine-containing systems, another system (R694LR) was created from
the R694L system where the midspan leucine was spontaneously mutated back to the
WT sequence and simulated with MD. In R694LR, the first water molecule interacted
with the midspan arginine within 9 ns. The water profile for R694LR resembled the
WT1, WT2, and WT3 systems within 100 ns. This simulation confirmed that the
WT MSD can cause influx of water into the membrane during ns timescales and
that solvation of the midspan arginine is not a result of the initial condition from
pulling the peptide into the membrane. In Panel C, the cholesterol-free systems
were similarly solvated, with an average of 6.7 ± 0.44 (SE) water molecules uniquely
associated with the midspan arginine. Evidently midspan arginine solvation does not
require cholesterol and this so-called “water defect” is a robust feature of the MSD.
The midspan arginine has 5 hydrogens available to hydrogen bond with water
molecules and lipid headgroups. The actual number of hydrogen bonds a transmem-
brane arginine forms in bilayers depends on lipid type and arginine bilayer depth,
but it ranges from 3 to 5 [61, 96, 106]. Figure 3.9 A and B show that the midspan
arginine engaged in 3 to 4 hydrogen bonds throughout the trajectories in both the
cholesterol-containing and cholesterol-free systems. Figure 3.9 C and D show the
number of hydrogen bonds from R694 to water in the systems. Hydrogen bonds
to water represented most of the hydrogen bonds; the remainder are to lipid phos-
phate oxygens, lipid carboxyl oxygens, and (for the cholesterol-containing systems),
cholesterol hydroxyl oxygens (data not shown).
Transmembrane helices that have a charged residue that “snorkels” to water and
lipid headgroups often tilt to facilitate the solvation. This was indeed the case with
the MSD in both cholesterol-containing and cholesterol-free bilayers, as seen in Fig-
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Figure 3.8: Number of water molecules within 4 A˚ of protein vs amino acid that each water
molecule is uniquely attributed to during equilibrium MD. All statistics are from the last 100 ns of
each trajectory and error bars represent standard deviation.
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Figure 3.9: Number of total hydrogen bonds donated from R694 vs simulation time in ns for
A) cholesterol-containing systems WT1, WT2, WT3, and R694LR and B) cholesterol-free systems
WT1∆Chol, WT2∆Chol, and WT3∆Chol. Number of hydrogen bonds donated from R694 to water
vs simulation time in ns for C) cholesterol-containing systems WT1, WT2, WT3, and R694LR and
D) cholesterol-free systems WT1∆Chol, WT2∆Chol, and WT3∆Chol
ure 3.10. In Panel A, the WT systems in cholesterol-containing membranes had
similar tilts from membrane normal during the last 100 ns that fluctuate around
19.5◦ ± 1.4 (SE). In Panel B, the tilt of the helix in the R694LR system was similar.
However, the R694L systems sampled an average of 14.3◦ ± 3.1 (SD) from membrane
normal. The midspan leucine did not “snorkel” and therefore the R694L had a lower
tilt than the WT1, WT2, and WT3 systems. The WT systems in cholesterol-free
bilayers, shown in Panel C, also tilted but to widely variable degrees: averages of 7.2◦
± 3.0, 22.6◦ ± 3.0, 39.5◦ ± 3.7 (SD) for WT1∆Chol, WT2∆Chol, WT3∆Chol, re-
spectively. This suggests that the cholesterol-containing and cholesterol-free bilayers
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accommodated the “water defects” differently.
Figure 3.10: Tilt angle in degrees vs simulation time in ns.
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3.3.5 Localized thinning near water defect was dependent on cholesterol
The comparison of membrane thickness in intervals of 100 ns is useful for as-
sessment of membrane stability and for evaluation of any changes in the membrane
environment near the peptide. Shown in Figure 3.11 are 2D maps of membrane
thickness and standard deviation in 100 ns intervals for WT1, R694L, WT1∆Chol,
and WT3∆Chol systems. The maps are centered on the location of the peptide,
of which the backbone is shown in black dots overlaid on the maps. The midspan
arginine (or leucine) nonhydrogen sidechain is shown in white dots. The cholesterol-
containing membranes were generally thicker than the cholesterol-free membranes
here, as cholesterol has been shown to order the lipid tails in the liquid phase, which
increases the thickness [16, 107]. The membrane thickness and fluctuations for WT1
were consistent across the 3 time intervals and were uniform over the total area, except
near the peptide. The WT1 membrane was thinner near the peptide and water defect
and had greater fluctuations there. The R694L system had uniform thickness and
fluctuations, even at the location of the peptide. Therefore, the membrane thinning
in the WT1 system was due to the midspan arginine and water defect specifically, and
not the presence of the peptide. In the cholesterol-free systems shown (WT1∆Chol
and WT3∆Chol), membrane thickness and fluctuations were not uniform and the
peptides were located in areas of different thicknesses. In WT1∆Chol, the peptide
was located in a thicker section of the membrane, but the thickness was fluctuating
there. In WT3∆Chol, the peptide was in a thinner section of the membrane and the
thickness was also fluctuating there. In the cholesterol-free membranes, the thickness
of the location of the peptide correlated to its tilt angle; the thinner the membrane
section, the greater the tilt. It seemed that in the cholesterol-containing membranes,
the water defect influenced the local thickness but in the cholesterol-free membranes,
the water defect did not influence the local thickness. This helps explain why the
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peptide tilts were consistent in the cholesterol-containing membranes with a water
defect, but the tilts in the cholesterol-free membranes with a water defect depended
on the thickness at the exact location of the peptide. This relationship can be seen
in Figure 3.12. However, the water defect did cause thickness fluctuations in both
cholesterol and cholesterol-free membranes, which functioned to solvate the midspan
arginine also.
The cholesterol-containing membranes did not change appreciably in thickness
between intervals. The initial membrane configuration seemed to be stable on a 100
ns timescale. The cholesterol-free bilayers did change from the first 100 ns interval
to the last 2 intervals, as it took them over 100 ns to equilibrate (see Figure 3.2).
Maps of membrane thickness and standard deviation for the other systems are shown
in Appendix Figure 3.18. Importantly, the membrane thickness map for the protein-
free DPPC/Chol system was completely uniform, with an average of 48 A˚. This is
consistent with both experimental and computational studies [16, 107].
We have shown that membrane thickness fluctuations helped solvate the water
defect. Next, we look at actual water movement in the inner leaflet. In Figure 3.13
are 2D maps of average minimum distance of water from the bilayer interface in the
inner leaflet and standard deviation for WT1, WT1∆Chol, and WT3∆Chol systems.
The WT1 system had uniform average minimum water location from the membrane
interface, except at the water defect. Water molecules came to within 14 A˚ of the WT1
bilayer middle there and the membrane thickness there is 37.5 A˚. The cholesterol-free
systems had the closest water molecules in thin areas of the membrane and at the
water defect. For WT1∆Chol, the protein was in an area with 43 A˚ thickness and
water molecules came to within 11.6 A˚. For WT3∆Chol, the protein was in an area
with 32.5 A˚ thickness and water molecules came to within 11.8 A˚. The water distance
was also highly fluctuating at the water defect for all three systems. It seems that
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Figure 3.11: Maps of membrane thickness, L, (top) in A˚ and standard deviation, σL, (bottom) in
A˚ for the WT1, R694L, WT1∆Chol, and WT3∆Chol systems during 100 ns intervals of equilibrium
MD. Overlaid on the maps are the x and y positions of the non-hydrogen atoms of the peptide (black
circles) and the 694 residue (white circles) from the last frame of the trajectories. The N- and C-
termini are labeled.
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Figure 3.12: Average tilt angle in degrees from last 100 ns vs membrane thickness at protein in A˚
for WT peptides in cholesterol in black closed circles (WT1, WT2, WT3, R694LR), mutant peptide
in cholesterol in black open circle (R694L), and WT peptides in cholesterol-free membranes in red
triangles (WT1∆Chol, WT2∆Chol and WT3∆Chol).
water and lipid headgroups worked in unison to accommodate the midspan arginine.
Maps of average minimum water distance along membrane normal in the inner leaflet
for the other systems are shown in Appendix Figure 3.19.
3.3.6 Summary and conclusions of Aim I
A model of HIV-1 gp41 monomeric MSD in a model viral bilayer was shown to be
stable as an α-helical peptide in a membrane spanning configuration for 300 ns. The
highly-conserved midspan arginine was solvated due to water and membrane thickness
fluctuations in both cholesterol-containing and cholesterol-free bilayers. The water
defect did not depend on local lipid distribution or system initial condition. However,
only in bilayers with cholesterol was the helix tilt unambiguously associated with the
water defect. In the cholesterol-free bilayers, the helix tilt also depended on the
membrane thickness. In the cholesterol-containing bilayers, membrane thinning was
localized at the water defect; without solvation of a midspan residue, there was no
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Figure 3.13: Maps of average minimum distance along membrane normal in the inner leaflet of
water molecules from global center of mass of lipid bilayer, Min (top), in A˚ and standard deviation,
σMin, (bottom) in A˚ for WT1, WT1∆Chol, and WT3∆Chol systems.
membrane thinning at the peptide. A consistent helix tilt may be important for a
protein that trimerizes, even though it is not known if or when the MSD exists as
a trimer. We can also speculate on the importance of a water defect at the MSD.
Since gp41 is a metastable protein whose conformational rearrangements into a more
stable state are thought to be the driving force for HIV-1 fusion/infection, perhaps
the water defect represents a local membrane metastability that also helps drive the
fusion process.
3.3.7 Appendix
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Figure 3.14: Local mass density (within 6 A˚ of protein) in amu/A˚3 along membrane normal in A˚
during equilibrium MD of lipid tails, lipid headgroups, and cholesterol for A) WT1, B) WT2, and
C) WT3 systems. All statistics are from the full 300 ns of each trajectory.
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Figure 3.15: Comparison of WT systems run with more aggressive (WT1) and less aggressive
(WT1c) MD parameters (see Methods). A) Collective variable (RMSD of backbone compared to
perfect helix) in A˚ vs simulation time in ns and histogram of RMSD vs frequency for equilibrium
MD of WT1c. B) Number of water molecules within 4 A˚ of protein vs amino acid that each water
molecule is uniquely attributed to during equilibrium MD for WT1 and WT1c systems. All statistics
are from the last 100 ns of each trajectory and error bars represent standard deviation. C) Tilt angle
in degrees vs simulation time in ns for WT1 and WT1c systems.
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Figure 3.16: Sn1 order parameters vs carbon atom index from last 100 ns of trajectory.
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Figure 3.17: A, B, D, F) Global mass density in amu/A˚3 along membrane normal in A˚ during
equilibrium MD for various components: lipid tails, lipid headgroups, water, and cholesterol for
DPPC, DPPC/Chol, R694LR, and WT1c systems. C, E) Local mass density in 102 amu/A˚3 along
membrane normal in A˚ during equilibrium MD for various components: protein, local water (defined
as within 4 A˚ of protein), and midspan arginine for R694LR and WT1c systems. All statistics are
from the last 100 ns of each trajectory.
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Figure 3.18: 2D maps of membrane thickness, L, (left column) in A˚ and standard deviation, σL,
(right column) in A˚ for the WT2, WT3, WT1c, R694LR, DPPC/Chol, WT2∆Chol, and DPPC
systems from equilibrium MD. Overlaid on the maps are the x and y positions of the non-hydrogen
atoms of the peptide (black circles) and the 694 residue (white circles) from the last frame of the
trajectory. The N- and C- termini are labeled. Statistics are from the last 100 ns of each trajectory.
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Figure 3.19: 2D maps of average minimum distance of water molecules along membrane normal in
inner leaflet from global center of mass of lipid bilayer, Min (left column), in A˚ and standard devia-
tion, σMin, (right column) in A˚ for WT2, WT3, WT1c, R694LR, R694L, DPPC/Chol, WT2∆Chol,
and DPPC systems. All statistics are from the last 100 ns of each trajectory.
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4. Aim II: Dynamics of HIV-1 model viral membranes with cholesterol
4.1 Introduction to Aim II
A common model membrane for HIV-1 research is 50/50 DPPC/Chol and this
composition has been studied both experimentally and computationally. Computa-
tional studies of membranes with 50% cholesterol are strongly influenced by the ini-
tial coordinates of the lipids, because diffusion of this composition occurs on longer
timescales than previously computationally accessible [108, 109]. Therefore, less is
known about the dynamics and configurations of bilayers relevant for HIV-1 than
other model membranes with much less cholesterol. In Aim I, three replicas (WT1,
WT2, and WT3) were used to represent different local lipid distributions around the
MSD, since sufficient diffusion around the protein was beyond the 300 ns timescale
of Aim I. Another way of sampling phase space besides multiple replicas is to run
extremely long MD (infinitely, in theory) to generate an approximation of the ensem-
ble average, according to the ergodic principle. Since HIV-1 fusion and infection are
strongly influenced by lipid composition, Aim II simulated WT1, WT2, and R694L
from Aim I for 6.45 to 9.98 µs, an order of magnitude greater than previous MD,
using the highly specialized, state-of-the-art computer Anton [110, 111] to explore
ergodicity of the membrane and study the dynamics of monomeric MSD with lipids
and cholesterol molecules in a model viral bilayer. We aimed to answer the following
questions:
1. Is the diffusion of lipids and cholesterol during 10 µs MD consistent with ex-
periments?
2. Is the water defect stable on this timescale?
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3. Is this timescale long enough for the membrane to “forget” its initial state?
4.2 Methods
4.2.1 µs trajectories on Anton
Systems WT1, WT2, and R694L after 300 ns NPT MD from Aim I were further
simulated for 9.98, 6.45, and 8.06 µs NPT MD, respectively, on the Anton super-
computer [110, 111]. As before, the CHARMM force field with recent lipid-based
corrections and explicit TIP3P water were used [75–78]. Verlet integration was ap-
plied every 2 fs and long-range electrostatics were handled with the Gaussian Split
Ewald method [112]. The pressure, set to 1 atm, was handled semi-isotropically with
the Martyna-Tobias-Klein barostat and the Nose´-Hoover thermostat was set to 310
K [80, 113]. Trajectories were visualized with VMD [74]. See Appendix C for the
complete list of configuration parameters.
Trajectories from Anton were only available with all coordinates wrapped into the
primary periodic cell. The trajectories had to be postprocessed into unwrapped ver-
sions in order to compute mean-squared displacements. Unwrapping of all molecules
from one frame to the next to determine the “true” displacement requires that the
displacement of each molecule is smaller than half the periodic box (in each carte-
sian direction). In order for unwrapping to generate true displacements and to avoid
intra-leaflet fictitious forces, center-of-mass motion was not removed during the simu-
lations. The thermostat available in the Anton software was the Nose´-Hoover, which
rescales velocities. This type of thermostat with no removal of center-of-mass motion
resulted in cooling of WT1, WT2, and R694L systems to 306.7, 302.6, and 302.2 K,
respectively. This cooling is shown in Appendix Figure 4.9 and is related to the fly-
ing ice cube effect [114–116]. However, the temperatures stabilized in our simulations
instead of continuously cooling.
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4.2.2 Calculations of observables
Lipid order parameters, tilt of helix with respect to membrane normal, unique
water molecules per residue, 2D membrane thickness maps, and local density were
calculated the same way as in Chapter 3. For calculation of diffusion coefficients, the
trajectories were rewrapped in x and y around the leaflet center of mass and then
unwrapped in x and y. The mean-squared displacements (MSD) of lipids, cholesterol
molecules, and protein were measured over all time origins for each leaflet indepen-
dently. Using Einstein’s equation,
Dlat = lim
t→∞
1
4Nt
N∑
i=1
〈[ri(t)− ri(0)]
2〉, (4.1)
the lateral diffusion coefficients were calculated when the MSD was linear with time
(for time intervals between 1 and 5 µs for DPPC/cholesterol or between 0.1 and
2.5 µs for peptide). Graphs of the mean squared angular displacements (MSAD) vs
time were used to similarly calculate the 1D rotational diffusion coefficients. The
tilt of cholesterol molecules was calculated by determining the angle between mem-
brane normal and a vector connecting carbons C3 and C17. The location of either
cholesterol hydroxyl oxygen or DPPC phosphorous atoms in 4 x 4 A˚2 sections of the
peptide-centered trajectories were used to create maps of average mass in amu. The
radial distribution function was calculated using the g(r) plugin in VMD and a δ of
0.1 A˚ [117]. The pair selections chosen were the cholesterol hydroxyl oxygen O3 with
respect to itself, DPPC phosphate oxygens O11, O12, O13, O14 to cholesterol hy-
droxyl hydrogen H3’, and DPPC carbonyl oxygen O22 or O32 to cholesterol hydroxyl
hydrogen H3’. See Appendix Figure 4.10 for a picture of each lipid component with
important atoms highlighted.
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4.3 Aim II results
4.3.1 System properties were consistent between ns and µs MD
System properties measured from 6.45 to 9.98 µs MD for WT1, WT2, and R694L
systems were consistent with measurements from 300 ns MD in Aim I. The WT and
mutant peptides remained membrane spanning for the duration of the trajectories.
The peptides were α-helical and stable, as seen in plots of RMSD in Appendix Fig-
ure 4.11. The midspan arginines of WT1 and WT2 remained solvated, while the
mutant did not have a water defect, as seen in Appendix Figure 4.12. Also con-
sistent with Aim I, the MSD peptides had a tilt angle associated with either the
presence (WT1 and WT2) or absence of a water defect (R694L), as seen in Appendix
Figure 4.12.
4.3.2 Local membrane distribution changed slowly
Next we examined initial condition bias of protein-embedded membrane simula-
tions and the degree to which erogodicity is achieved in these simulations on the
multiple microsecond timescale. Figures 4.1 and 4.2 show snapshots along membrane
normal of the lower leaflets of the three systems at the beginning and end of the
trajectories. Either lipids or cholesterol molecules within 6 A˚ of the protein at the
beginning of the simulation are colored uniquely in the peptide-centered snapshots.
The locations of these same membrane components are also highlighted at the end
of the simulation and show that membrane components initially local to the peptides
mostly diffused away on the microsecond timescale. However, these snapshots also
indicate that the lipid and cholesterol molecules in the WT2 and R694L systems did
not move as far as in the WT1 system, as some of the molecules still remain in the
vicinity of the peptide.
The mass densities of lipid and cholesterol molecules local to the peptide quantita-
49
Figure 4.1: DPPC lipid molecules within 6 A˚ of protein in the lower leaflet in bright colors at the
first simulation frame (ti) and the same molecules at the final simulation frame (tf ). Lipid molecules
are in light gray and cholesterol in dark gray. The protein is represented as a black spiral. The blue
square represents the x and y periodic boundary conditions.
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Figure 4.2: Cholesterol molecules within 6 A˚ of protein in the lower leaflet in bright colors at the
first simulation frame (ti) and the same molecules at the final simulation frame (tf ). Cholesterol
molecules are in dark gray and the protein is represented as a black spiral. Lipid molecules are not
shown for clarity. The blue square represents the x and y periodic boundary conditions.
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tively assess ergodicity in the systems and are shown in Figure 4.3. The local density
profiles of the first two µs are different for each system, reflecting the choice in Aim
I to create systems with different initial conditions. Complete ergodicity would be
achieved if WT1 and WT2, which are replicas, have the same local density at the
end of the simulations. The density profiles of the last two µs are similar, and the
peptides in WT1 and WT2 have greater local cholesterol than local DPPC density
in the lower leaflet. The profiles are not equal, however, and these trajectories are
evidently not long enough for equilibration of lipid distribution.
Figure 4.3: Mass density in amu/A˚3 within 8 A˚ from protein along membrane normal for cholesterol
(red squares), lipid headgroups (cyan circles), and lipid tails (black diamonds) for A, B, C) first 2
µs MD and D, E, F) last 2 µs MD for WT1, WT2, and R694L systems.
The trajectories did not show any clustering between membrane components,
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which remained randomly distributed. This was determined by radial distribution
function, g(r), over time and averaged for each system. The g(r) for specific DPPC
oxygen atoms with respect to cholesterol hydroxyl hydrogen atoms or cholesterol
hydroxyl oxygen atoms with respect to itself were identical between systems, as seen
in Appendix Figure 4.13, and are consistent with similar, previous studies [107].
The locations of bilayer components that interact with the MSD for many µs in
the lower leaflet are shown by 2D maps of either average cholesterol hydroxyl oxygen
or DPPC phosphorous mass in amu per frame for the 3 systems in Figure 4.4. WT1
had uniform distribution of cholesterol but increased DPPC mass near the protein,
while WT2 and R694L had increased cholesterol density. The bilayers were able to
better configurationally sample on the µs timescale, but there were still lipid-peptide
or cholesterol-peptide interactions that persisted for the majority of the length of the
simulations.
Figure 4.4: Maps of average mass (amu) per frame 20 A˚ from protein in the lower leaflet for WT1,
WT2, and R694L. First row, cholesterol hydroxyl oxygen mass and second row, DPPC phosphorous
mass. The peptides are centered in x and y and the azimuthal orientation of the midspan residue
(arginine for WT1 and WT2 and leucine for R694L) is aligned along the x-axis in each map, as
shown by the white arrow in the bottom right box.
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4.3.3 Translational and rotational diffusion of HIV-1 model bilayer com-
parable to experiments
The 6.45 to 9.98 µs simulations allowed sufficient statistics for analysis of the
lateral diffusion of lipids, cholesterol molecules, and peptides. Figure 4.5 (panels A,
B, C) shows the mean squared displacement (MSD) for each membrane component
for each leaflet from the unwrapped trajectories vs time. Ballistic motion can be
seen at short times and diffusive motion can be seen starting between 100 ns and 1
µs. The diffusion coefficients were calculated using Einstein’s relation and are shown
in Table 4.1. Since WT1, WT2, and R694L had the same bilayer composition and
include a 27-residue peptide, theoretically the diffusion measurements should be the
same. However, as seen in Table 4.1, Dlat (10
−9 cm2/s) varies from 0.41 to 7.49 for
DPPC, 0.47 to 8.90 for cholesterol, and 0.20 to 1.83 for the protein. WT1 and WT2
differed only in their initial coordinates, yet WT1 had 3x faster diffusion in UL for
both bilayer components and 5x faster diffusion in LL for both, compared to WT2.
Also, all three systems had higher diffusion coefficients in the upper leaflets, compared
to the lower leaflets.
The lateral diffusion coefficients measured here are consistent with experimental
measurements on membranes with similar compositions, although experiments can be
highly variable. Experimental measurements of lateral diffusion on model bilayers are
sensitive to temperature, lipid composition and phase, cholesterol and protein con-
tent, ion concentration, hydration level, and timescale of measurement. Quasielastic
neutron scattering covers picosecond timescales of diffusion, while fluorescence cor-
relation spectroscopy (FCS) and fluorescence recovery after photobleaching (FRAP)
cover longer timescales, for instance. NMR measurements on membranes with the
same composition used here (50% DPPC and 50% cholesterol) and at 309 K deter-
mined the lateral diffusion coefficient to be 33 and 37 x 10−9 cm2/s for DPPC and
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cholesterol, respectively [118]. This is within an order of magnitude of the diffusion
coefficients here, although the timescales of NMR and simulations are not exactly
comparable. Our simulations also support the trend that cholesterol has a higher
diffusion rate that DPPC. Another NMR study on bilayers composed of 58% DPPC
and 42% cholesterol by Filippov et al. measured lateral diffusion coefficients of 25
to 75 x 10−9 cm2/s for DPPC at 308 K and 313 K, respectively [119]. Scherfeld et
al. measured 4.5 x 10−9 cm2/s for a dye using FCS at room temperature on a 50/50
DPPC/chol model bilayer [120]. Computational studies on diffusion of model bilay-
ers are also sensitive to the same parameters as above, as well as force field, system
size, area per lipid, MD parameters, and simulation length. Previous studies that
measured lateral diffusion coefficients of lipids, cholesterol molecules, and/or proteins
in model bilayers were performed for up to 150 ns in cholesterol-free bilayers and up
to 500 ns in cholesterol-containing bilayers with all-atom MD [108, 121–125]. Falck
et al. simulated a membrane with the same composition at 323 K and measured Dlat
as 2 x 10−9 cm2/s for both DPPC and cholesterol. However, the authors cautioned
that the 100 ns simulation was probably not sufficiently long for diffusion measure-
ments on a system with 50% cholesterol [109]. Although it is complicated to directly
compare experimental and computational Dlat measurements of similar systems, our
coefficients are comparable to both.
Also in Figure 4.5 (panels D, E, F) are plots of mean squared angular displacement
(MSAD) for each membrane component for each leaflet vs time. The rotational
diffusivities had the same trends as Dlat: WT1 had faster rotational motion that
WT2 or R694L and the upper leaflets were faster than the lower leaflets. Both the
MSD and MSAD for the peptides (C and F) show a sudden drop in diffusivity from
103 to 104 ns; this is due to the lack of statistics for the peptide at this long timescale
and not to a dramatic change in diffusivity. There are 74 to 91 cholesterol or DPPC
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Figure 4.5: Mean-squared displacements vs time for A) DPPC, B) cholesterol (excluding flipflops),
and C) the WT or mutant MSD. Dashed lines show best fits of 4DT t for 1000< t <5000 ns (100<
t <2500 ns for peptide) to extract the translational diffusion constant. Orientational mean-squared
displacements vs time for D) DPPC, E) cholesterol (excluding flipflops), and F) the WT or mutant
MSD. Dashed lines show best fits of 2DRt for 1000< t <5000 ns (100< t <2500 ns for peptide) to
extract the rotational diffusion constant. In A, B, D, E, “UL” and “LL” refer to upper and lower
leaflets, respectively. C and F both show a sudden drop in diffusivity from 103 to 104 due to the
lack of statistics for the peptide at long timescales.
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Table 4.1: Species diffusion coefficients
Diffusion coefficients Translational (10−9 cm2/s) Rotational (10−2 rad2/ns)
System WT1 WT2 R694L WT1 WT2 R694L
Protein 1.83 0.63 0.20 0.040 0.019 0.0063
DPPC UL 7.49 2.71 0.95 0.98 0.31 0.19
LL 4.98 1.01 0.41 0.73 0.17 0.087
Cholesterol UL 8.90 2.90 1.20 24.4 12.8 1.44
LL 6.50 1.34 0.47 22.0 11.1 6.91
Temperature (K) 306.7 ±1.22 302.6 ±1.22 302.2 ±1.24 306.7 ±1.22 302.6 ±1.22 302.2 ±1.24
molecules in a leaflet, so the other graphs do not exhibit such a drop in diffusivity.
4.3.4 Inter-system discrepancies in diffusion manifested by interdepen-
dent variables
The inter-system trends of lateral and rotational diffusivities described above cor-
related to the observed temperature in each system. The cooler systems, WT2 and
R694L, had lower diffusivities than the warmer system, WT1. As mentioned in Meth-
ods, observed system temperatures (306.7, 302.6, and 302.2 K for WT1, WT2, and
R694L respectively) were lower than the setpoint (310 K), as seen in Appendix Fig-
ure 4.9. This was a result of the specific choice of MD parameters (no removal of
center-of-mass motion and Nose´-Hoover thermostat) to observe true displacements
and to avoid fictitious forces. Besides diffusion, the temperature differences between
systems resulted in changes in unit cell area, lipid order parameters, and membrane
thickness, which we now examine.
The unit cell area, defined by MD periodic boundary conditions, was used to de-
termine membrane area. The systems had two lipid components and a peptide, so
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determining area per lipid is neither exact nor trivial. Figure 4.6 shows the unit cell
area over the simulation time for all 3 systems. The WT1 system had a stable unit
cell area of ∼69 nm2 for the entire trajectory, which correlated with its stable system
temperature. The WT2 and R694L systems relaxed into smaller unit cell areas of
∼64 nm2, after ∼3 µs, as a result of system cooling. Also evident in Figure 4.6 is
when the R694L system occasionally experienced undulatory motions for up to 1 µs
in duration, also shown in a snapshot in Figure 4.6. These undulatory motions are
represented in the graph by extreme changes in unit cell area that are not reflec-
tive of the “true” membrane surface area at that time and have been seen in other
studies as well [126]. Mean squared displacements measured during undulatory and
nonundulatory periods for the R694L trajectory revealed no correlation with diffu-
sion. Therefore, the lowest diffusion coefficients of R694L cannot be attributed to
undulations along with temperature.
Figure 4.6: Left, total unit cell area during µs simulations. Right, snapshot of R694L with
undulation motion.
Lipid tail order parameters in all 3 systems over the entire trajectories also reflect
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system cooling and resulting area compression, but are overall similar to other, shorter
studies of similar bilayers [107]. As shown in Figure 4.7, both leaflets of WT1 had
lower SCD than the leaflets of WT2 or R694L. This indicates that both leaflets of
WT1 were less ordered (or more disordered) than the other systems. Also, the WT1
upper leaflet was more disordered (lower SCD) than its lower leaflet. Both WT2 and
R694L also had more disordered upper leaflets than their lower leaflets. These trends
correlate with the trends in Dlat: R694L had the highest SCD and the slowest diffusion
while WT1 had the lowest SCD and the fastest diffusion.
The lipid tail order parameters also showed changes with time. Appendix Fig-
ure 4.14 shows SCD of each leaflet of R694L over every 2 µs. The upper leaflet
increased in order from the first 2 µs compared to the rest of the trajectory, which
correlated to initial equilibration of R694L to a new configuration at a lower temper-
ature and a lower total unit cell area. The same trends in SCD occurred for WT2 in
both leaflets, as seen in Appendix Figure 4.15, which also required a few µs to relax
into a smaller unit cell area. WT1 increased in order from 4 to 6 µs but then decreased
to its initial order, as seen in Appendix Figure 4.16. As expected, unit cell area and
DPPC order parameters are also correlated with membrane thickness. Histograms
of average membrane thickness in 4 x 4 A˚2 patches for each system is shown in Ap-
pendix Figure 4.17. The more ordered systems, WT2 and R694L, had the thickest
membranes and the most disordered system, WT1, had the thinnest membrane.
The slight cooling of the simulations, resulting in ∼4 K difference between WT1
and WT2/R694L systems, resulted in large differences in membrane area, diffusion,
membrane thickness, and lipid order. The cooler systems, WT2 and R694L, had 5%
smaller area and ∼10x lower diffusion. The correlation between temperature and
membrane area, diffusion, membrane thickness, and lipid order have been observed
in other systems [127]. The simulations here support these observations, although
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Figure 4.7: DPPC order parameters for each chain over entire trajectory. “UL” and “LL” refer to
upper and lower leaflets, respectively.
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the temperature differences were the unintentional result of specific MD parameters.
4.3.5 Discrepancies in inter-leaflet diffusion examined
All three systems had faster diffusion in their upper leaflets compared to their
lower leaflets. Both WT1 and WT2 systems had a stable water defect in the lower
leaflets, as discussed earlier (Appendix Figure 4.12) and in Aim I. Since the lower
leaflets of all 3 systems had smaller diffusion coefficients than the upper leaflets, the
trend cannot be attributed to the water defect. However, all 3 peptides had the
same sequence from residues 15 to 27, including two terminal arginines, which may
influence cholesterol or lipid movement. We did not specifically test for this, though.
4.4 Cholesterol flip-flops are rare events
On the µs timescale, several cholesterol molecules attempted to “flipflop” from
one leaflet to the other in WT1 and R694L. (No DPPC molecule underwent this
motion in any of the systems.) Figure 4.8 shows the z-position and tilt angle of
the 3 flipfloping cholesterol molecules vs simulation time. The WT1 system had two
such molecules: one flipped quickly to a different leaflet in ∼30 ns (A) but the other
lingered in the membrane interface for over 2 µs before returning to its original leaflet
(B). The quickly flipflopping cholesterol tilted 0.5 ns before it changed z-position;
the tilt continued to increase until it reached a maximum. The cholesterol reached
the other leaflet 15 ns after reaching the maximum tilt. The cholesterol in panel
B remained in the membrane interface for over 2 µs, and then tilted 75 ns before
returning to the original leaflet. Jo et al. calculated the PMF of cholesterol flipflop in
DPPC and stated that a cholesterol tilts before a change in position [128]. The quickly
flipflopping cholesterol of WT1 supported this, but the other cholesterol in WT1 (B)
did not tilt first before moving. R694L had one cholesterol (C) that remained in the
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membrane interface for the majority of the simulation. This may be because it did
not achieve a high enough tilt (like the cholesterol in A and D). Although we have not
thoroughly investigated this process, these 3 rare events suggest that a cholesterol will
remain in the membrane interface unless it is able to increase its tilt by over 150◦ and
immediately flipflop to the other leaflet. The 3 flipflops here, on a ns to µs timescale
in a liquid ordered membrane, do not agree with Choubey et al. [129], who observed
faster and more numerous events in a membrane suggested to be at an induced phase
transition. However, our simulations may have had a higher free energy barrier to
flipflop due to the higher percentage of cholesterol. Compared to experiments, the
timescales for cholesterol flipflops here and in Choubey et al. are still considered fast,
although there are not necessarily overlaps in timescales of measurements. A recent
update to the cholesterol force field parameters in CHARMM36 improved accuracy
regarding parallel orientations of cholesterol in the membrane interface; simulations
on Anton, such as these here, were not able to utilize them [79]. It is unknown how
they would affect the cholesterol flipflopping process.
The flipflopping cholesterols were removed from the diffusion measurements in Ta-
ble 4.1 because the flipflopping motion complicates the meaning of a lateral diffusion
measurement. Including or excluding these 3 cholesterols did not significantly change
Dlat. WT1 had the same coefficient for cholesterol in the upper leaflet and a decrease
from 6.53 to 6.50 x 10−9 cm2/s in the lower leaflet with cholesterol flipflop exclusion.
Since R694L had one cholesterol that remained in the membrane interface for the
majority of the simulation, the diffusion coefficient in the lower leaflet decreased from
1.02 to 0.47 x 10−9 cm2/s with the quickly-moving cholesterol removed from measure-
ment. It remains unknown if, and to what extent, the cholesterols that remained in
the membrane interface in WT1 and R694L influenced DPPC or leaflet motion.
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Figure 4.8: Z-positions of oxygen atoms vs simulation time in µs of A, B) 2 cholesterol molecules
from WT1 and C) one cholesterol molecule from R694L that flip-flop during the trajectories. D, E,
F) Tilt of cholesterol ring with respect to membrane normal vs simulation time, corresponding to
cholesterol molecules in (A, B, and C).
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4.5 Summary and conclusions of Aim II
Simulations of WT1, WT2, and R694L for 9.98, 6.45 and 8.06 µs MD allowed the
model viral bilayers of ∼50% DPPC and ∼50% cholesterol to better configurational
sample their phase space. This timescale allowed calculation of diffusion coefficients,
which agree with experiments, however inter-system differences are a result of tem-
perature differences of 0.4 to 4.5 K. Temperature control for simulations on the 10
µs timescale therefore requires careful attention as these simulations show for the
first time, to the best of our knowledge, that small temperature differences result in
large differences in membrane area, lateral and rotational diffusion, lipid order, and
membrane thickness at temperatures between 300 and 310 K. The simulations did not
achieve complete ergodicity, which suggests that bilayers with 50% cholesterol require
longer than 10 µs for proper sampling. A recent umbrella sampling calculation of the
binding of a small peptide to a bilayer came to the same conclusion when it required
windows of 1.5 µs [130].
4.6 Appendix
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Figure 4.9: Simulation temperature (K) over time for WT1, WT2, and R694L.
Figure 4.10: All-atom renderings of a cholesterol (left) and a DPPC (right) molecule to highlight
atoms selected for analysis of cholesterol tilt, 2D maps of average mass, and radial distribution
function. The atoms not used for analysis are highlighted by element: hydrogen in white, carbon in
light blue, oxygen in red, and nitrogen in dark blue. Atoms used in analysis are in different colors:
in cholesterol, C3 and C17 in pink, hydroxyl oxygen O3 in green, and hydroxyl hydrogen H3’ in
black; in DPPC, phosphorous atom in black, phosphate oxygens in pink, and carbonyl oxygens in
green.
65
Figure 4.11: RMSD of backbone compared to t = 0 in A˚ vs simulation time in µs.
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Figure 4.12: Top, number of water molecules within 4 A˚ of protein vs amino acid that each water
molecule is uniquely attributed to during MD. All statistics are from the entire trajectories and error
bars represent standard deviation. Bottom, tilt angle of helix in degrees vs simulation time in µs.
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Figure 4.13: Radial distribution systems for cholesterol hydroxyl oxygen with respect to itself and
cholesterol hydroxyl hydrogen with respect to either the lipid phosphate oxygen atoms or the lipid
carbonyl oxygen atoms for WT1, WT2, and R694L.
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Figure 4.14: DPPC tail order parameters (sn1 and sn2) vs carbon atom index every 2 µs for upper
and lower leaflets of R694L.
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Figure 4.15: DPPC tail order parameters (sn1 and sn2) vs carbon atom index every 2 µs for upper
and lower leaflets of WT2.
70
Figure 4.16: DPPC tail order parameters (sn1 and sn2) vs carbon atom index every 2 µs for upper
and lower leaflets of WT1.
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Figure 4.17: Histograms of average membrane thickness in 4 x 4 A˚2 patches for WT1, WT2, and
R694L systems.
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5. Aim III: Modeling of HIV-1 gp41 MPER-MSD trimer in a
cholesterol-containing bilayer
5.1 Introduction to Aim III
Since the fusion-active spikes of HIV-1 are trimeric (trimers of dimers gp120 and
gp41) and gp41 MSD contains the common α-helical transmembrane interaction motif
GXXXG, it is reasonable to suppose that MSD exists as a trimer either in the native,
unliganded spike or at some point during fusion. As mentioned, there are currently
no crystal or NMR structures of the MSD. In this thesis, we have used comprehensive
simulations with a segment-based approach to model the monomeric MSD peptide
in a viral bilayer (Aim I) and to investigate the ergodicity of the model viral bilayer
on µs timescales (Aim II). Information obtained from Aims I and II enabled us to
now rationally construct a model of a MSD trimer. Model building of membrane
proteins is sometimes performed in hydrophobic slabs, coarse-grained membranes, or
all-atom membranes; however, the enumeration of the MSD was performed in vacuum
due to the specific attributes of the MSD-membrane environment. Enumeration in
a hydrophobic slab or implicit membrane would neglect the importance of the wa-
ter defect and the requirement of cholesterol for fusion [131], as studied in Aim I.
Enumeration of all trimer models in an all-atom membrane is too computationally
expensive as the slow diffusion of lipids and cholesterol, studied in Aim II, requires
at least µs long trajectories for partial ergodicity of the model membrane. Enumer-
ation in vacuum is therefore the only acceptable approach for the HIV-1 gp41 MSD.
Also, van der Waals forces have been found to be more important for transmembrane
helical interactions than ionic or hydrophobic forces [132–135], further supporting a
vacuum enumeration. Therefore, the MSD trimers were enumerated in vacuum and
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then the lowest energy model was equilibrated in a model bilayer.
Finally, we wished to augment this model with structures of the trimeric MPER
to produce a MPER-MSD trimer model in a viral bilayer. Since MPER is amphi-
pathic, several experimental structures of MPER exist. Experimental structures of
MPER include a kinked α-helix in micelles and a postfusion crystal structure of helical
MPER as an extension of 6HB, for instance [24, 26]. In the native, unliganded spike,
MPER’s epitopes are not accessible to antibodies. Recent cryo-EM structures of the
unliganded spike show a “stalk” form for the exposed ectodomain of gp41 [19, 136].
Although there is no consensus about how MPER plays a role in fusion, the putative
prefusion structure has been proposed to be an α-helical trimer parallel to membrane
normal with the epitope regions located in the trimer interface. A similar structure
was recently crystallized with an isoleucine zipper motif [25]. Also, a recent NMR
structure of the MPER trimer in a DPC micelle claims to be a putative prefusion
intermediate state [137]. These trimeric MPER structures enabled us to model a
prefusion MPER-MSD trimer in a model viral bilayer. With this model, we aimed to
answer the following questions:
1. Is the lowest energy MSD trimer consistent with what is known about the
conserved residues?
2. Are the MSD and MPER-MSD trimer models stable on the 100 ns timescale?
3. Are the midspan arginines still solvated and do the models provide any clues to
a poration mechanism?
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5.2 Methods
5.2.1 Enumeration of MSD trimer
A large discrete set of trimer configurations spanning the entire relevant ranges of
several internal variables were enumerated in vacuum using an α-helical MSD peptide
determined to be a stable structure from previous group work [1]. The peptide was
placed parallel to the z-axis and triplicated. The three peptides were then rotated
around the z-axis (α, 10 to 360◦ in increments of 10◦), around the x-axis (β, -45 to
45◦ in cosine distributed increments of 5◦), and around the z-axis (γ, -45 to 45◦ in
increments of 5◦), resulting in unique transformations specified by Euler angles. The
peptides were then rotated to be threefold symmetric around the z-axis and translated
equilaterally away from the initial trimer center (5 to 25 A˚, in increments of 1 A˚). An
example tcl script for the enumeration is located in Appendix B. This enumeration
gave ∼270,000 structures; all structures were sorted by potential energy (vdW and
electrostatics) and the lowest energy structure was found. In addition to enumeration
of the WT peptide with an endoplasmic snorkeling midspan arginine, other enumer-
ations were performed for the MSD with an exoplasmic snorkeling midspan arginine,
with the WT BaL sequence, and with neutral N- and C- termini.
5.2.2 Setup and equilibration of MSD trimer
In order to generate a system with the lowest-energy trimer in a bilayer, the WT1
system with monomeric MSD in a bilayer was used as a starting point. Two other
monomeric MSD peptides were placed vertically above the bilayer. This system was
minimized and equilibrated for 2 ns NPT MD with protein backbones constrained.
One of the peptides above the bilayer was rotated around the z-axis using the rotating
constraints feature in NAMD, at a rate of 90◦ per 100 ps for 100 ps MD. Steered MD
(SMD) was used to pull the two peptides individually into the bilayer with a force
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constant of 7 kcal/mol/A˚2, a velocity of 1 x 10−5 A˚/timestep in the z-direction, and
for a total of 14 ns. During SMD, the secondary structure of the SMD peptide was
restrained with extra bonds, the lipid and cholesterol molecules were restrained in
the z-direction, and the remaining soluble peptide was fixed. After SMD, excess
water and 4 obtrusive lipid and cholesterol molecules were deleted and the system
was briefly equilibrated for 2 ns. Next, targeted MD (TMD) was used to pull the
three peptides into the lowest-energy vacuum structure with a force constant of 200
kcal/mol/A˚2 for 5 ns. The resultant trimer model had an RMSD of less than 0.5 A˚
with respect to the vacuum trimer. The trimer-membrane system was run for 100
ns NPT MD with the backbone constrained to allow lipid, cholesterol, and water to
relax around the trimer. Then the protein constraints were released and MD was
continued for 150 ns. The same parameters as the WT1c system in Chapter 3 were
utilized here.
5.2.3 Preliminary MPER simulations
Preliminary simulations of MPER in water were performed using a monomeric
NMR structure (PDB 2PV6). The monomeric MPER was solvated in a water box,
neutralized, ionized, and minimized. To explore the ensemble of MPER in water,
three replicas were equilibrated for 500 ps NPT MD and run for 50 ns NVT MD. The
simulations were run at 310 K using CHARMM27, TIP3P water, periodic boundary
conditions, and a grid spacing of 2.0 A˚. Verlet integration was applied every 2 fs and
nonbonded forces were shifted off from 8 to 9 A˚.
5.2.4 Setup and equilibration of MPER-MSD trimer
Trimeric MPER was excised from a recent crystal structure (PDB 3G9R), aligned
to the N-terminal of trimeric MSD after 100 ns of equilibration described above, cova-
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lently bonded, minimized, and equilibrated for 50 ns with constraints on nonhydrogen
protein atoms. Then, the constraints were released and the system was run for 133 ns
NPT MD. The same parameters as the WT1c system in Chapter 3 were utilized here.
This system had 97,825 atoms, including ions, 231 DPPC molecules, 275 cholesterol
molecules, 2,520 protein atoms, and ∼15,000 water molecules. The system size was
105 x 100 x 85 A˚3.
5.2.5 Production run of MPER-MSD trimer
The MPER-MSD trimer after 133 ns MD was simulated for 10.973 µs NPT MD
on the MD-specialized machine, Anton [110, 111]. As before, the CHARMM force
field with recent lipid-based corrections and explicit TIP3P water were used [75–78].
Verlet integration was applied every 2 fs and long-range electrostatics were handled
with the Gaussian Split Ewald method [112]. The Langevin thermostat was set to
310 K and the Martyna-Tobias-Klein barostat was set to a semi-isotropic pressure of
1 atm [80, 81, 113]. Trajectories were visualized with VMD [74]. See Appendix C for
the complete list of configuration parameters.
After ∼11 µs, the system was converted to NAMD format and was equilibrated
with the protein backbone constrained. The trimer was then pulled upwards in a
constant-velocity SMD simulation for 12 ns where forces were applied to the MPER
backbone, the force constant was 10 kcal/mol/A˚2, and the velocity was 2 A˚/ns.
During SMD, lipid molecules farther than 20 A˚ from the trimer were constrained
in the z-direction. NAMD parameters for the SMD simulation were the same as the
WT1c system in Chapter 3.
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5.2.6 Calculations of observables
The potential energy of the vacuum models was assessed by summation of the
Lennard-Jones potential and the Coulombic potential using ǫ, σ, and atomic charges
from the CHARMM force field. The radial distribution function was calculated using
the g(r) plugin in VMD and a δ of 0.1 A˚ [117]. The pair selections chosen were the
cholesterol hydroxyl oxygen and either a particular residue or the K681 NH+3 atoms.
The lipid order parameters, number of unique waters per residue, maps of membrane
thickness, and maps of water penetration were calculated similarly to Chapters 3 and
4.
5.3 Aim III Results
5.3.1 Lowest energy structure of MSD trimer in vacuum is determined
from ∼270,000 possible geometric configurations
As a first step towards an equilibrated trimeric MSD, all potential geometric
models of the MSD trimer were systematically constructed, resulting in ∼270,000
unique Euler transformations. The α angle varied from 0 to 360◦, however the β
and γ angles were constrained to be between -45 and 45◦. This was based on the
assumption that the MSD is a single pass transmembrane helix, with the N-terminus
in the upper leaflet, the C-terminus in the lower leaflet, and the improbability of the
MSD to be found horizontal in the membrane. It was also assumed that the trimer
was three-fold symmetric. The resulting ∼270,000 models were evaluated for potential
energy. Figure 5.1 shows the histogram of potential energies for all negative energy
structures. The lowest energy structure for the WT sequence with an endoplasmically
snorkeling arginine (WTendo in Table 5.1) was found to be a left-handed trimer with
a rotation of 310◦ around z, -45◦ around x, 40◦ around z, and each helix translated 7 A˚
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laterally from the trimer center of mass. Interestingly, the highly conserved GXXXG
motifs, postulated to mediate transmembrane helical interactions, were found to be
interacting in the vacuum structure, as seen in Figure 5.2.
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Figure 5.1: Histogram of potential energy for all enumerated WT structures with a endoplasmi-
cally snorkeling arginine and potential energy per dimer less than 0 in kcal/mol. The inset shows
placement of the 4 lowest energy trimers.
Changing the WT sequence from HxB2 to BaL (difference of 5 residues, see Ap-
pendix Table 5.2) did not alter the lowest energy structure appreciably. Neither did
changing the terminal atoms from the traditional charged termini (3H-N+-CH-C=O...
for N-terminus and O−-C=O... for C-terminus) to neutral termini (CH3-(C=O)-NH-
CH... for N-terminus and CH3-NH-C=O... for C-terminus). (Please refer to NTER,
CTER, ACE, and CT3 in the CHARMM force field for further information). The
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Table 5.1: Lowest energy Euler transformations for the MSD
Energy Energy Equilateral
Monomer per dimer per structure α(◦) β(◦) γ(◦) distance Handedness
(kcal/mol) (kcal/mol) (A˚)
WTendo -18.6 -55.8 310 -45.0 40 7 L
WTBaLendo -17.8 -53.4 310 -45.0 45 6 L
neutWTendo -18.3 -54.9 310 -45.0 45 6 L
neutWTBaLendo -18.1 -54.3 310 -45.0 45 6 L
WTexo -18.0 -54.0 30 -39.4 -40 7 R
neutWTexo -17.5 -52.5 170 -39.4 40 8 L
lowest energy trimers with an endoplasmic snorkeling arginine were all left-handed,
have the same α and β angles, and similar γ angles. Each monomer was 6 to 7 A˚
from the trimer center of mass. The WT monomers were also enumerated with an
exoplasmic snorkeling arginine, even though previous group work determined that
the endoplasmic arginine was lower in energy and more mechanistically realistic with
translocon-mediated env translation than the exoplasmic snorkeling arginine [1]. The
enumeration of the MSD with an exoplasmic snorkeling arginine resulted in a right-
handed trimer where R694 reaches towards the upper leaflet. Enumeration of the
exoplasmic snorkeling arginine with neutral termini resulted in a left-handed trimer
but R694 was not positioned to snorkel and was located horizontally in the middle of
the bilayer. This structure is probably not stable in a membrane environment.
5.3.2 MSD trimer is not stable during 150 ns MD
The lowest energy MSD trimer in vacuum with an endoplasmic snorkeling arginine
(Figure 5.2) was then placed in a bilayer (50% DPPC and 50% cholesterol) and
simulated for 150 ns NPT MD. During the last 50 ns, the trimer in the bilayer
continuously increased in RMSD with respect to the vacuum structure, as seen in
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Figure 5.2: Snapshots of the lowest energy MSD trimer model with endoplasmically snorkeling
arginines: midspan arginine in blue, glycines in GXXXG motif in green, other residues in silver.
Figure 5.3. This indicated that the trimer is not stable on 150 ns MD timescales.
The simulation did not support the GXXXG motif as a trimerization motif or as
stronger than lipid/cholesterol-protein interactions. There is also the possibility that
the lowest-energy trimer in vacuum is not a low energy structure in membrane nor
stable in a membrane environment. The angle of each helix in the vacuum model from
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membrane normal was ∼20◦ greater than the tilt of the monomeric WT peptides in
the cholesterol-containing bilayers (Chapter 3). This discrepancy between the ideal
tilt of the trimer helices in vacuum and the ideal tilt of the monomeric helix in a
bilayer, to accommodate the water defect, was perhaps the reason for the increasing
RMSD of the trimer. Also, the MSD trimer may require other segments of gp41 to
trimerize, such as MPER, the gp41 segment N-terminal to MSD.
5.3.3 MPER stabilized the MSD trimer for 133 ns MD
Next, it was investigated whether the addition of trimeric MPER, the segment
N-terminal to MSD, was necessary to stabilize the MSD trimer in a membrane envi-
ronment. Therefore, an appropriate trimeric MPER structure was chosen. Prelimi-
nary simulations were performed of MPER in a water box to generate a collection of
trajectories. Three replicas with different initial velocities were simulated for 50 ns
NVT. The three trajectories quickly diverged from the initial NMR structure in ∼5
ns, as seen in Figure 5.4. Each trajectory sampled around a different RMSD with re-
spect to the initial structure. This indicates MPER is quite flexible and probably has
highly heterogeneous ensembles in water and membrane. Therefore, MPER cannot
be enumerated in water or membrane as straightforward as with the MSD α-helix.
However, there are many experimental structures of soluble or liposome-associated
MPER. All structures with only partial MPER (such as merely the CRAC domain)
were removed from consideration as well as structures complexed with antibodies.
Therefore, the putative prefusion crystal structure of trimeric MPER [25], also left-
handed, was covalently added to the N-terminus of the MSD trimer from the branched
off simulation of the trimer in bilayer after 100 ns MD with constrained backbones.
After equilibration with constraints, the MPER-MSD system was subjected to uncon-
strained MD for 133 ns, where it stabilized ∼3 A˚ RMSD, as seen in Figure 5.5. Clearly
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Figure 5.3: In white, vacuum MSD trimer model. In blue, MSD trimer model after 150 ns.
Bottom, RMSD vs simulation time.
the addition of trimeric MPER stabilized the trimeric MSD on the 100 ns timescale.
Next, the simulation of the unconstrained MPER-MSD trimer was continued for ∼11
µs to determine if the structure was stable on µs timescales.
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Figure 5.4: RMSD of backbone vs simulation time for three MPER replicas. The configuration
after 50 ns is shown on the right with the same color scheme as Figure 1.1: tryptophans in blue
(W664, W668, W670, W676), CRAC domain in yellow (L677, W678, Y679, I680, K681), and CRAC
tryptophan in green (W678).
5.3.4 MPER-MSD trimer rearranges to new configuration on µs timescale
The MPER-MSD trimer (after 133 ns unconstrained MD) was simulated for an
additional ∼11 µs. It took ∼5 µs to settle into a different state, at which point it was
stable for the remaining 6 µs, as seen in Figure 5.6. This new configuration was 7 A˚
RMSD from the initial structure. The main observation is that the GXXXG motifs
were no longer interacting, as seen in Figure 5.6, although the N-terminal residues of
MPER were still close together. The right-hand panel of Figure 5.6 shows the trimer
backbone near K681 (in green), which is the last residue in the CRAC motif and the
dividing residue between MPER and MSD. After 11 µs, the three lysines interacted
in the trimer interface and cloistered water molecules and a cholesterol molecule.
Radial distribution functions (g(r)) between the three lysines and cholesterol hydroxyl
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Figure 5.5: Top left, RMSD of backbone of trimeric MPER-MSD vs simulation time in ns. Top
right, MPER-MSD trimer model after 133 ns MD: lipid headgroups in red, lipid tails in white,
cholesterol in yellow, water in cyan, MSD (residues 682 to 707) in orange, and MPER (residues 660
to 681) in green. Bottom left, MPER-MSD trimer model after 133 ns MD (MPER in red, MSD in
blue) compared to vacuum trimer (MPER in light red, MSD in light blue). Bottom right, top view
of MPER N-terminus and bottom view of MSD C-terminus.
oxygens show that cholesterol interacted with K681, specifically with its terminal
positively charged atoms, NH+3 (top panel of Figure 5.7). Other residues both N- and
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C-terminal to K681 did not interact as strongly with cholesterol hydroxyl oxygens
(bottom three panels of Figure 5.7). This interaction between K681 and cholesterol
was unique to this configuration. Similar g(r) for shorter trimeric simulations and
the monomeric simulations from Chapter 4 are shown in Appendix Figure 5.11. Both
the MPER-MSD trimer after 133 ns and the MSD trimer after 150 ns did not have
as sharply defined or as high a value of g(r) at short distances.
Figure 5.6: Top left, RMSD of backbone atoms vs simulation time for MPER-MSD trimer. Right,
MPER-MSD trimer model after 11 µs MD: lipid headgroups in red, lipid tails in white, cholesterol
in yellow, water in cyan, MSD (residues 682 to 707) in orange, and MPER (residues 660 to 681)
in green. Bottom left, environment near K681, shown from N-terminus, at 11 µs: L681 in green, 3
waters in blue, cholesterol in yellow, and backbone in grey.
This MPER-MSD trimer configuration after 11 µs MD still solvated the three
midspan arginines, but did not display any water defects near the midspan arginines.
The number of unique water molecules that solvated each residue for each helix,
graphed in Appendix Figure 5.12, shows water molecules solvated K681 (as shown
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Figure 5.7: Radial distribution function, g(r), vs distance (in nm) between cholesterol hydroxyl
oxygen and residues 676 to 685 or residue 681 NH+3 atoms.
in Figure 5.6) and R694. However, maps of average minimum water depth along
membrane normal show that water did not penetrate the bilayer in the lower leaflet,
even at the midspan arginines. Water penetrated the bilayer in the upper leaflet at
the trimer, creating an upper leaflet water defect, as seen in Figure 5.8. As before,
water penetration near the trimer was strongly fluctuating.
87
Figure 5.8: Maps of average minimum distance along membrane normal in both leaflets of water
molecules from global center of mass of lipid bilayer, Min (top), in A˚ and standard deviation, σMin,
(bottom) in A˚.
Perhaps the absence of the lower leaflet water defects can be attributed to the
“sinking” of the trimer in the bilayer, relegating water defects unnecessary. The
midspan arginines did not need to snorkel as they were located in the solvated lipid
headgroups. Indeed, if the backbone of MPER experiences an upward force at a
constant velocity, the water defects quickly reestablished themselves in ∼10 ns, as
seen in Figure 5.9. This characteristic would probably be helpful for poration of the
membrane by decreasing the energy barrier to fusion. The upwards force may be
biologically relevant during the prefusion intermediate stage, when gp41 bridges the
cell and viral membranes.
The trimeric MPER structure initially chosen for the MPER-MSD trimer model,
as mentioned before, is a putative prefusion trimer crystallized with an isoleucine zip-
per motif to facilitate the trimerization [25]. The crystal structure agrees qualitatively
with the inability of antibodies to access MPER prefusion as the epitope regions are
located in the MPER interface. The model of MPER moves away from this struc-
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Figure 5.9: Z-distance (y axis) and SMD force (y2 axis) vs simulation time in ns for SMD pulling
simulation. Snapshots of trimer at 0, 6, and 12 ns: on left, trimer in orange, R694 in blue, K681 in
green, and water in cyan surface; on right, water in blue.
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ture, as shown in Figure 5.10. The RMSD of MPER with respect to the initial crystal
structure (PDB 3G9R) and to the configuration of the model at timestep 0 of 11 µs
MD (after equilibration with constraints and equilibration without constraints for 133
ns) increased within the first µs and then stabilized to within 4 or 5 A˚. The MPER
model also stabilized to ∼5 A˚ RMSD with respect to a recent trimeric MPER NMR
structure that is purported to be a prefusion intermediate structure [137]. This NMR
structure (PDB 2LP7), assembled in a DPC micelle, also has its N-terminal residues
interacting. Along the C-terminus, the helices increase in distance away from each
other. Also, the epitope regions are exposed and more accessible to antibodies, which
qualitatively agrees with antibody activity during the prefusion intermediate stage of
infection. The MPER-MSD model after 11 µs resembled the NMR structure in that
the C-terminal residues of MPER have moved away from each other, exposing the epi-
tope regions, while the N-terminal residues still interacted. The MPER-MSD model
was ∼5 A˚ RMSD from the NMR structure. The crystal structure, NMR structure,
and model after 11 µs are compared in Figure 5.10.
An interpretation of the relationship between the three trimeric MPER structures
is that the trimeric MPER in the MPER-MSD model is an intermediate structure
between the prefusion crystal structure (PDB 3G9R) and the prefusion intermediate
NMR structure (PDB 2LP7) and would need much longer simulation time to tran-
sition to the more open structure. Also, the three structures are reflections of their
construction and environment. The crystal structure is aqueous, the NMR struc-
ture is encapsulated with a micelle, and the model is exposed to both a cholesterol-
containing membrane and solvent. The experimental structures are not restricted by
an MSD trimer and the experimental conditions, by necessity, ignore the influence of
cholesterol. All three structures lack restrictions from the spike N-terminal to MPER.
While the prefusion MPER structure is supported in a metastable state by gp120 and
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Figure 5.10: Top panel: RMSD of backbone atoms vs simulation time with respect to frame 0
of MPER (black lines), putative prefusion crystal structure of MPER (PDB 3G9R, red lines), and
putative prefusion intermediate NMR structure of MPER (PDB 2LP7, blue lines). Bottom panel:
MPER backbones shown for comparison, from left to right, PDB 3G9R in red, model after 11 µs in
grey, and PDB 2LP7 in blue. Sidechains of CRAC motif rendered in yellow.
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perhaps the rest of gp41, the prefusion intermediate MPER structure is on the brink
of experiencing strong forces emanating from 6HB formation by the heptad repeat
sections. Without further research, it is merely speculation on the correlation be-
tween the three MPER trimer structures. However, the trimeric MPER-MSD model
is the first all-atom simulation for this region of gp41 and can suggest mechanisms
for antibody interaction, cholesterol sequestration, or poration potential from upper
and lower leaflet water defects.
5.3.5 Summary and conclusions of Aim III
An all-atom model of trimeric MPER-MSD was constructed and equilibrated in
a cholesterol-containing bilayer, representing the first such simulation in literature.
Initially, the lowest energy MSD trimer identified in vacuum was equilibrated in a
bilayer, but required trimeric MPER, excised from a putative prefusion crystal struc-
ture, to stabilize. Two orders of magnitude longer MD (to 11 µs) culminated in
the MPER-MSD model transitioning to a different, stable configuration that quali-
tatively resembled a recent prefusion intermediate NMR structure. The model was
almost completely immersed in the cholesterol-containing bilayer, but the helices near
the CRAC motif separated to allow sequestration of a cholesterol molecule and wa-
ter. The model potentially shows a transition structure between the prefusion and
prefusion intermediate stages of HIV-1 fusion and infection.
5.3.6 Appendix
Table 5.2: Comparison of HIV-1 gp41 MSD peptide sequences
HxB2 K L F I M I V G G L V G L R I V F A V L S I V N R V R
BaL K I F I M I I G G L I G L R I V F S V L S I M N R V R
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Figure 5.11: Radial distribution function (g(r)) vs distance (in nm) between cholesterol hydroxyl
oxygen and residue 681 (left panel) or residue 681 NH+3 atoms (right panel) for previous systems A,
B) 133 ns MPER-MSD trimer, C, D) 150 ns MSD trimer, E, F) WT1, G, H) WT2, and I, J) R694L.
93
Figure 5.12: Number of water molecules within 4 A˚ of protein vs amino acid that each water
molecule is uniquely attributed to during equilibrium MD. All statistics are from the full trajectory
and error bars represent standard deviation.
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6. Aim IV: Role of the dimerization motif, GXXXG, in the MSD of
trimeric HIV-1 gp41
6.1 Introduction to Aim IV
The GXXXG motif has previously been identified as a transmembrane, α-helical
dimer interaction motif for right-handed helices either as dimers or in complex, multi-
protein structures in the bilayer [48, 138, 139]. HIV-1 MSD has this conserved motif,
where the first X is also a glycine (GGXXG). It has been speculated that the motif
is important for MSD trimerization, either in the native structure or during fusion.
Experiments suggest a more complex role though. Replacement of the MSD with
that of CD4, which also contains GGXXG, did not affect fusion [140]. Replacement
of the MSD with glycophorin A (GpA), a well known transmembrane dimer with
the GXXXG motif, impaired fusion; function was not restored with mutation to
the dimerization motif [46]. The dimerization or trimerization ability of the motif
is not sufficient for MSD function and perhaps the residues surrounding the motif
may modulate the affinity of interhelical interactions [138]. Mutants of the MSD
GXXXG had normal expression, processing kinetics, membrane incorporation, and
surface expression, indicating that perhaps the GXXXG motif is not important for
expression, but for fusion. In fact, mutations to one or more of the glycines decreased
the fusion activity of HIV [51, 52].
Although the lowest energy WT MSD trimer in vacuum from Aim III had in-
teracting GXXXG residues, the motif did not sustain trimerization of excised MSD
transmembrane peptides on the 100 ns timescale in MD simulations. Aim IV in-
vestigated dimers of the WT MSD on similar timescales in order to assess if the
HIV-1 MSD sequence is capable of dimerization. We aimed to answer the following
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questions:
1. Does the GXXXG motif sustain dimerization of the WT dimer on the 100 ns
timescale?
2. How does the midspan arginine affect dimerization?
3. What do these simulations reveal about the probable oligomeric state of the
HIV-1 MSD?
6.2 Methods
6.2.1 Enumeration of MSD dimer
The enumeration of Euler configurations for the WT and R694L dimer used the
same procedure as described in Chapter 5, except the peptides were rotated twofold
symmetric around the z-axis and not threefold symmetric before translation. These
systems were referred to as WT-LED and R694L-LED.
6.2.2 Setup and equilibration of MSD dimer
The lowest energy MSD dimer, WT-LED, was generated by branching off the
SMD simulation described in Section 5.2.2 after the 2nd peptide was pulled into the
bilayer. The remaining peptide above the bilayer was deleted. The starting structure
for the dimer simulation now consisted of two monomeric MSD peptides in a bilayer;
this structure was equilibrated for 5 ns. Then, 5 ns of TMD was used to assemble
the dimer in the membrane. The dimer backbone was constrained for 50 ns while
lipids and water relaxed around it. An interfering cholesterol and lipid molecule were
deleted and the constraints were continued for 50 ns. The constraints were released
and the dimer was simulated for 150 ns. This system had 64,205 atoms, including
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ions, 151 DPPC molecules, 183 cholesterol molecules, 916 protein atoms, and ∼10,000
water molecules. The system size was 90 x 80 x 80 A˚3.
A low energy WT dimer was also constructed in the bilayer and equilibrated,
similarly to WT-LED, as a different initial condition. This system was referred to as
WT-D.
6.2.3 Setup and equilibration of MSD mutant dimers
A R694L dimer was also enumerated to find the lowest energy mutant dimer.
A system with the R694L dimer, known as R694L-LED, was prepared similarly to
WT-LED by starting with the same initial structure as above, before TMD. The two
peptides in random locations were mutated and the entire system was reneutralized,
ionized, and minimized before 5 ns of TMD. The dimer was also constrained for 100
ns and then released for 150 ns of production MD.
Another mutant was created by branching off the WT-D system after 50 ns of
backbone constraints, mutation of the midspan arginines to leucines, reneutralization,
minimization, and simulation with protein constraints for 50 ns. The new system,
known as R694L-D, was then simulated for 150 ns production run.
6.2.4 Calculations of observables
The radial distribution function was calculated using the g(r) plugin in VMD and
a δ of 0.1 A˚ [117]. The pair selections were the two sidechain hydrogens (HA1 and
HA2) of one of the glycines in GGXXG from one helix to another. The number
of unique water molecules per residue was calculated similarly to Chapter 3. The
NAMD parameters for the dimer simulations were the same as in Chapter 3.
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6.3 Aim IV results
6.3.1 Lowest energy structure of MSD dimer in vacuum is determined
from ∼270,000 possible geometric configurations
The enumeration of WT and R694L dimers resulted in lowest energy structures
that are ∼-10 kcal/mol lower in energy per dimer than the lowest energy trimer
structures. WT-LED and R694L-LED therefore had the lowest energy per structure,
-57.8 and -58.0 kcal/mol, respectively, compared to -55.8 for the WT trimer. Along
with WT-LED and R694L-LED, the Euler transformations are shown for a low energy
dimer, WT-D, in Table 6.1. Similarities existed between WT-LED, R694L-LED, WT-
D, and the vacuum trimers with an endoplasmically snorkeling arginine. All were
left-handed with interacting GXXXG motifs. This is not surprising for the dimers,
as GXXXG is a known dimerization motif.
Table 6.1: Lowest energy Euler transformations for dimer enumeration
Energy Energy Equilateral
Monomer per dimer per structure α(◦) β(◦) γ(◦) distance Handedness
(kcal/mol) (kcal/mol) (A˚)
WT-LED -28.9 -57.8 30 -42.3 30 7 L
WT-D -19.5 -39.0 0 -42.3 40 5 L
R694L-LED -29.0 -58.0 30 -42.3 30 7 L
Conversely, the majority of structurally known transmembrane dimers with the
GXXXGXXXG glycine zipper are right-handed and the rest are also predicted to
be right-handed [139]. However, a recent 6 A˚ cryo-EM structure of the uncleaved,
unliganded spike finds the α-helical MSD region to be a left-handed trimer with a
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crossing angle of 35◦, although the MSD cryo-EM region might match the ectodomain
region of an earlier cleaved spike cryo-EM [19, 136, 141]. The crystal structure of the
MPER trimer with an isoleucine zipper utilized for the model in Chapter 5 and an
NMR structure of the MPER trimer with a bacterial trimerization domain in a DPC
micelle are both left-handed [25, 137]. Also, the 6HB post-fusion structure is left-
handed [21]. The MSD may be an exception among right-handed transmembrane
α-helices with a glycine motif; the HIV-1 experimental studies cited above support a
left-handed trimer for the MSD.
6.3.2 Production runs of dimer were stable
The lowest energy dimer, WT-LED, and a low energy dimer, WT-D, were both
simulated for 150 ns in a cholesterol-containing bilayer and both reached RMSDs of
∼4 A˚ with respect to their vacuum structure, as shown in Figure 6.1A. The dimers
remained α-helical and membrane spanning for the duration of the trajectories. The
increase in RMSD over the trajectory is partly a result of the decrease in tilt angles
of both helices of WT-D and WT-LED, as seen in Figure 6.1B, although the GXXXG
motifs remained associated. The decrease in tilt angles can be seen in the snapshots
of Figure 6.1, where the light blue dimers are the vacuum structures and the dark
blue dimers are the structures after 150 ns MD for WT-LED and WT-D. Both dimers
show associated GGXXG residues with decreases in tilt angles.
The water defects associated with the midspan arginines were similar to the water
defects explored in Aim I and the number of unique water molecules per residue for
both helices are shown in Figure 6.2. WT-LED has 4.1 ± 1.2 and 5.9 ± 1.4 (SD)
unique water molecules at the midspan arginines while WT-D has 4.6 ± 1.4 and 5.7
± 1.3 (SD). This compares very well with the average of 4.8 unique water molecules
at the midspan arginines of the monomeric MSDs in Aim I.
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Figure 6.1: A) RMSD of WT-LED and WT-D backbone vs simulation time. B) Tilt angle of all
helices with respect to membrane normal vs simulation time. Snapshots: initial structure in light
blue and structure after 150 ns in dark blue for WT-LED and WT-D. GGXXG residues in vdW.
The lowest energy mutant dimer, R694L-LED, and a mutant dimer, R694L-D,
also remained α-helical and membrane spanning during the 150 ns trajectories. The
RMSD with respect to vacuum structure vs simulation time is shown in Figure 6.3A
for both dimers. Both R694L-LED and R694L-D reached ∼4 A˚ RMSD during the
trajectories. Similarly to the WT dimers, the mutant dimers had decreases in tilt
angle of both helices, as shown in Panel B and accompanying snapshots. The thickness
of the membrane probably causes the helix tilts to decrease in all systems, as evidently
there is a hydrophobic mismatch initially between the vacuum structures and the
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Figure 6.2: Number of unique waters per residue for each helix of A) WT-LED and B) WT-D,
with standard deviation.
membrane. Decrease of tilt angle was also seen in Aim III with the 11 µs simulation
of the MPER-MSD trimer. The lowest energy vacuum structures of the dimers and
trimers all have decreased tilt angles after simulation in a membrane that approach
the tilt angles of the monomeric MSDs in Aim I.
6.3.3 Interactions of GXXXG residues differed between MSD dimers and
trimers
Although the dimers reached ∼4 A˚ RMSD from their initial configurations, the
GXXXG motifs remained interacting. This can be seen more clearly with graphs
of radial distribution function over time for the dimers. Graphed in the Appendix
are g(r) vs distance in nm for atomic pairs of sidechain hydrogens of either residue
688, 689, 692 in helix 1 (H1) with respect to sidechain hydrogens of either residues
688, 689, 692 in helix 2 (H2), resulting in 9 potential interactions for WT-LED, WT-
D, R694L-LED, and R694L-D. The g(r) for the first 50 ns, middle 50 ns, and last
50 ns are shown as three lines in each graph (black, red, blue, respectively). The
first thing of note is that the g(r) profiles were not similar for WT-LED and WT-D
or for R694L-LED and R694L-D. For instance, WT-D had the greatest probability
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Figure 6.3: A) RMSD of R694L-LED and R694L-D backbone vs simulation time. B) Tilt angle
of all helices with respect to membrane normal vs simulation time. Snapshots: initial structure in
light blue and structure after 150 ns in dark blue for R694L-LED and R694L-D. GGXXG residues
in vdW.
for the pair of hydrogens from 689 in H1 to 688 in H2 and this profile was constant
with time, with a 1st peak at ∼3 A˚. The same graph for WT-LED also had a peak
at ∼3 A˚, but the probability was half that of WT-D and did vary with time. For
R694L-LED, its greatest probability was for residue 689 in H1 to residue 689 in H2.
However, the 1st peak decreased from 4.2 A˚ to 2.3 A˚ over the simulation, indicating
the atoms moved closer. For R694L-D, this interaction was constant and the 1st peak
remained at 3.0 A˚ over the trajectory. Overall, the dimers have strong interactions
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between GGXXG residues, but these interactions are not the same between systems
and sometimes change with time. Also, the midspan arginine did not have an effect
on the dimerization ability of the GGXXG motif, as the mutant dimers had as strong
and as close interactions as the WT dimers.
Also graphed in the Appendix are the same set of g(r) graphs for the trimer sim-
ulations from Aim III. The MSD trimer simulated for 150 ns shows much smaller
probability than the dimers and with 1st peaks greater than 5 A˚. This is consistent
with the conclusion in Aim III that the GGXXG motif was not able to sustain trimer-
ization on the 150 ns MD timescale. In contrast, the MPER-MSD trimer of Aim III
was able to sustain trimerization on the same timescale and the graphs reflect that.
The greatest interaction was with residue 688 of H1 to residues 688 in H2 and H3,
with a constant 1st peak at 3.7 A˚ over time. As discussed previously, these interac-
tions between GGXXG residues do not last at longer timescales, as the MPER-MSD
system that was simulated for 11 µs has extremely small g(r) and at larger distances
than the other systems.
Therefore, the g(r) profiles show that the dimers (both WT and mutant) can
sustain dimerization on the 150 ns timescale, while the trimers cannot. (Further
simulations, up to 10 µs, would be able to assess these dimeric interactions on a longer
timescale.) However, interactions between GGXXG residues seem to be nonspecific
as the profiles differed among the dimers and their replicates. The extra glycine in
MSD compared to the GXXXG motif may account for this flexibility. It is unknown
why gp41 or spike might need a stronger dimerization than trimerization ability at the
MSD. The ability of MSD to dimerize may be necessary during fusion for interactions
with other spikes or asymmetric 6HB formation [142]. Another instance may exist
after translation at the ER [7, 143]. Env proteins gp120 and gp41 are translated
in the ER as monomeric, covalently-linked gp160. Most gp160s trimerize, but other
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oligomeric forms are found. Dimeric gp160 may be a prerequisite for trimeric gp160, as
sequential oligomerization steps may be more plausible than concurrent trimerization.
Trimeric gp160 is then trafficked to the Golgi, where it is proteolytically cleaved.
6.3.4 Summary and conclusions of Aim IV
Previously, the presence of the GXXXG motif in the MSD (as GGXXG) was
not sufficient for trimerization, as the lowest energy MSD trimer in vacuum did not
remain trimerized in the bilayer on the 100 ns timescale in Aim III. Also in Aim III, the
addition of MPER stabilized the GGXXG-mediated trimerization on the 100 ns, but
not the 10 µs, timescale. However, Aim IV showed that the lowest energy WT dimer
(WT-LED) in vacuum remained dimerized, with persistent GGXXG interactions as
seen with g(r) over time. The lowest energy R694L dimer, R694L-LED, also remained
associated on the 100 ns timescale. So did other simulations with different initial
conditions of the WT and R694L dimers (WT-D and R694L-D). This indicates that
either the GGXXG residues have a more complex role in HIV fusion than mediating
trimerization or that the motif is required for dimerization. The MSDs may dimerize
during the HIV-1 lifecycle, such as oligomerization after translation at the ER, as
asymmetric 6HB formation, or as needed for interactions with other spikes during
fusion. Since the native structure of gp41 is metastable, a native MSD trimer may
be as well and require more or all of gp41 to stabilize with GGXXG interactions.
A simulation of the dimer for many µs can further indicate if the GGXXG residues
mediate dimerization, not trimerization, of the MSD or if there is something specific
about the MSD sequence that resists oligomerization, such as the midspan arginine
and associated water defect.
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6.3.5 Appendix
The following graphs show g(r) vs distance (nm) for the first, middle, and last
segments of the simulations (black, red, blue, respectively). The interaction pairs for
the dimers are the sidechain hydrogens of either residue 688, 689, 692 in helix 1 (H1)
with respect to sidechain hydrogens of either residues 688, 689, 692 in helix 2 (H2),
resulting in 9 potential interactions for WT-LED, WT-D, R694L-LED, and R694L-
D. For the trimers from Aim III simulated on the 100 ns timescale, the interaction
pairs are the sidechain hydrogens of either residue 688, 689, 692 in helix 1 (H1) with
respect to sidechain hydrogens of either residues 688, 689, 692 in helices 2 and 3 (H2
and H3). This was because interactions from H1 to H2, H2 to H3, and H1 to H3 were
similar to the pair H1 and H2/H3. This was not the case for the 11 µs MPER-MSD
trimer model, so the g(r) graphs for this simulation are for the pairs H1 to H2, H2 to
H3, and H1 to H3 in the final 3 figures. Note that the scale is not the same between
systems.
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Figure 6.4: Radial distribution function vs distance in nm for WT-LED. 0-50 ns in black, 50-100
ns in red, 100-150 ns in blue.
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Figure 6.5: Radial distribution function vs distance in nm for WT-D. 0-50 ns in black, 50-100 ns
in red, 100-150 ns in blue.
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R694L−LED
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Figure 6.6: Radial distribution function vs distance in nm for R694L-LED. 0-50 ns in black, 50-100
ns in red, 100-150 ns in blue.
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R694L−D
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Figure 6.7: Radial distribution function vs distance in nm for R694L-D. 0-50 ns in black, 50-100
ns in red, 100-150 ns in blue.
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150 ns MSD trimer
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Figure 6.8: Radial distribution function vs distance in nm for 150 ns MSD trimer from Chapter
5. 0-50 ns in black, 50-100 ns in red, 100-150 ns in blue.
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133 ns MPER−MSD trimer
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Figure 6.9: Radial distribution function vs distance in nm for 133 ns MPER-MSD trimer from
Chapter 5. 0-50 ns in black, 50-100 ns in red, 100-133 ns in blue.
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Figure 6.10: H1 to H2 radial distribution function vs distance in nm for 11 µs MPER-MSD trimer
model from Chapter 5. 0-4 µs in black, 4-8 µs in red, 8-11 µs in blue.
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Figure 6.11: H1 to H3 radial distribution function vs distance in nm for 11 µs MPER-MSD trimer
model from Chapter 5. 0-4 µs in black, 4-8 µs in red, 8-11 µs in blue.
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Figure 6.12: H2 to H3 radial distribution function vs distance in nm for 11 µs MPER-MSD trimer
model from Chapter 5. 0-4 µs in black, 4-8 µs in red, 8-11 µs in blue.
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7. Conclusion and future work
7.1 Thesis summary
In Chapter 3, Aim I characterized the solvation of the highly conserved midspan
arginine of the HIV-1 gp41 MSD in cholesterol-containing and cholesterol-free bilay-
ers using all-atom MD. The MSD was membrane spanning and stable as an α-helix
during 300 ns MD in bilayers with and without cholesterol. In cholesterol-containing
bilayers, the midspan arginine was solvated by a stable, but fluctuating, water defect.
Thinning of the membrane and thickness fluctuations near the defect also contributed
to arginine solvation. The mechanism also involved tilting the helix ∼20◦ with re-
spect to membrane normal to allow snorkeling of the arginine to lipid headgroups.
Mutation of the arginine to leucine (R694L) retained the α-helical stable state (as
determined by metadynamics) but exhibited no water defect and no local membrane
thinning or thickness fluctuations. Mutation of R694L back to arginine showed that
the midspan arginine was capable of water influx that was independent of initial con-
dition. In cholesterol-free bilayers, the MSD was also solvated, as the water defect
apparently did not depend on the presence or absence of cholesterol or the local lipid
composition. However, the tilt of the MSD depended on the location of the peptide
in the cholesterol-free bilayers and did not depend only on the presence of the water
defect. The midspan arginine of the MSD and its water defect may represent a local
membrane metastability and the consistent tilt of the helix may be important for
MSD trimerization in cholesterol-containing bilayers. This work has been published
in the Biochimica et Biophysica Acta - Biomembranes [144].
In Chapter 4, Aim II examined the dynamics of a model viral bilayer with 50%
cholesterol. Long MD of up to 9.98 µs allowed the cholesterol-containing model
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viral bilayers to achieve more configurational sampling than the 300 ns MD in Aim
I. Sufficient statistics allowed calculation of the diffusion coefficients of the lipids,
cholesterol molecules, and MSD peptides, which agreed with experiments. Observed
temperature differences of 4 K resulted in changes in diffusion, lipid order, membrane
area, and thickness. Despite simulation times of over an order of magnitude greater
than previous studies, the bilayers did not achieve complete configurational sampling,
due to the high concentration of cholesterol. This manuscript is in revision.
In Chapter 5, Aim III enumerated ∼270,000 configurations of trimeric MSD in
vacuum and determined the lowest-energy structure to have interacting GXXXG
motifs. This configuration was not stable in a bilayer for 150 ns, however the addition
of the experimental crystal structure of trimeric MPER stabilized the trimer for over
100 ns. The resulting trimeric MPER-MSD in a cholesterol-containing bilayer was
simulated for ∼11 µs NPT MD, allowing it to relax into a different configuration that
may precede the prefusion intermediate stage during HIV-1 fusion.
In Chapter 6, Aim IV examined the stability of dimeric MSD to elucidate the pos-
sible oligomeric form of MSD. The lowest energy WT and R694L dimers from similar
enumerations as in Aim III were simulated in cholesterol-containing bilayers. Unlike
the trimeric MSD and MPER-MSD models, the highly conserved GXXXG motifs re-
mained associated in the dimers. So did other initial conditions of the WT and R694L
dimers. This indicates that the highly conserved glycine motif may be required during
fusion for other roles besides trimerization. The manuscript encompassing Aims III
and IV is in preparation.
7.2 Future computational work
The next obvious step towards building a model of the HIV-1 spike is to augment
the MPER-MSD model created in this thesis with the ectodomain of gp41. A careful
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choice of experimental structure with regard to attached ligands, possible stage of
fusion, structure resolution, missing residues or atoms, etc. is necessary and further
refinement may be needed. In Aim III, the MPER-MSD model after 11 µs represented
a possible structure after prefusion but before the prefusion intermediate stage of
HIV-1 infection. Free-energy simulation techniques, such as string method, between
the model and the prefusion intermediate NMR of MPER can construct a low energy
pathway between both structures [145]. The prefusion intermediate state is accessible
to antibodies and the antibody binding process can also be modeled with MD.
As mentioned in the conclusion of Chapter 6, MD of the WT dimer, WT-LED,
for ∼10 µs can indicate if the GGXXG residues also interact on the µs timescale, as it
took several µs for the MPER-MSD trimer to relax to a different configuration where
the glycine motifs did not associate between the helices. This longer simulation can
add to the knowledge of the possible oligomeric form of MSD. Also, simulations of
mutations of GGXXG in the dimer can more thoroughly assess the role of this motif
in dimerization on 150 ns MD timescales. Simulations of a MPER-MSD dimer can
assess how other segments of gp41 potentially stabilize the dimer form.
As a first step towards a more realistic model viral bilayer, future research can
utilize the newly published sphingomyelin parameters [86] instead of using the satu-
rated lipid substitute, DPPC. Also, the cellular and viral bilayer leaflets do not have
an identical lipid distribution [146, 147] and this uneven distribution can be modeled
with MD.
7.3 Experimental validation
Solid-state NMR spectroscopy has observed the interaction of water with an argi-
nine from transmembrane peptides [64, 148]. Solid-state NMR has also examined the
interactions of cholesterol and DPPC [87]. The simulations in Aim I can be validated
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with similar experiments with WT and R694L MSD peptides in cholesterol-containing
and cholesterol-free bilayers. ATR-FTIR has been used on HIV-1 FP to determine
its orientation in native and cholesterol-extracted virus to determine tilt angle [149].
Perhaps this can be repeated for the MSD and compared to the tilt angles measured
in Aim I.
In Aim I, the MSD was modeled in cholesterol-free bilayers to represent a nonin-
fectious virus, since cholesterol is required for fusion. Viruses that have been treated
with methyl-β-cyclodextrin to remove cholesterol are no longer infectious. However,
the membrane environment local to the spikes during cholesterol extraction is un-
known. If cholesterol is first removed from directly near the spikes, then the spike
will exist in a more gel-like than liquid-ordered bilayer. Or, the spike could hold
onto local cholesterol during methyl-β-cyclodextrin treatment and this would change
the relevance of the pure DPPC simulations in Aim I. Investigations into methyl-
β-cyclodextrin-mediated cholesterol removal from the virus and associated changes
in membrane characteristics are currently being investigated by our collaborators at
Drexel College of Medicine, Department of Biochemistry and Molecular Biology, in
the lab of Dr. Irwin Chaiken.
Previous studies on the trimerization ability of HIV-1 MSD by TOXCAT sup-
ported oligomerization. Modeling of trimeric MSD asserted that trimerization of the
MSD was more stable with deprotonated midspan arginines [150]. Similar studies of
the severe acute respiratory syndrome (SARS) coronavirus spike protein membrane
spanning domain stated that the GXXXG motif is a trimerization motif using ToxR/-
TOXCAT assays and SDS-PAGE gels [151]. However, a later study that looked at
the SARS CoV S TMD in the context of the full-length sequence found that SDS-
PAGE of the WT and mutants of the GXXXG domain had similar ratios of oligomeric
forms [152]. This indicated that the GXXXG motif did not mediate oligomerization
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and that it is important to study the SARS TMD and other similar proteins in the
context of the full length protein. More careful studies of the oligomerization of HIV-1
gp41 MSD with mutagenesis to the GXXXG motif need to be performed and in the
context of full length gp41.
7.4 Thesis impact
The simulations in this thesis emphasized the importance of focusing first on a
small segment of a complex, oligomeric, transmembrane protein and that segment’s
local environment (Aims I and II) before building upon that knowledge to create
oligomeric structures (Aims III and IV). Specifically, this thesis asserts the following:
1. From extensive MD simulations of the excised HIV-1 gp41 MSD monomeric
peptide in cholesterol-containing and cholesterol-free model viral bilayers, the
mechanism of solvation of the highly conserved midspan arginine was deter-
mined to be a fluctuating water defect and the presence of cholesterol bestowed
stability to the tilt of the helix with respect to membrane normal. From these
simulations, we assert that cholesterol allows the spike to localize and control
the membrane thinning, thickness fluctuations, and water depth fluctuations.
This local metastability can then be “triggered” during fusion.
2. By configurational sampling through µs-long MD, small changes in system tem-
perature resulted in large differences in the dynamics of a model viral bilayer.
Diffusive motion was observed, despite the high percentage of cholesterol in the
system, and calculated diffusion coefficients of peptides, lipids, and cholesterol
molecules agreed with experiments. Model membranes with high cholesterol
content (such as a model of the HIV-1 viral membrane) continue to be diffi-
cult to simulate, as the cholesterol decreases the dynamics to timescales beyond
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simulations on even highly specialized, state-of-the-art supercomputers. Impor-
tantly, the water defect was stable on 10 µs and this further supports the water
defect as a feature of the spike.
3. Enumerations of ∼270,000 Euler transformations led to discovery of the lowest
energy trimeric MSD in vacuum, which was simulated for 150 ns but required
the addition of MPER to stabilize in a bilayer. The trimeric MPER-MSD model
was simulated for 11 µs in a cholesterol-containing bilayer to allow relaxation
into a lower energy structure. This represents the first simulation of a model of
trimeric MPER-MSD in a cholesterol-containing bilayer and it is a link between
the prefusion and prefusion intermediate recent experimental structures. Also,
this simulation is the first to show interaction between HIV-1 MPER CRAC
lysines to water and cholesterol and hopefully will inspire new insights into the
unique structure/function relationships of this region of HIV-1 gp41.
4. Comparison of dimeric MSD with previous trimeric MSD simulations revealed
that the GXXXG motif can more easily mediate dimerization and that perhaps
it has other roles in HIV-1 fusion than trimerization. Dimerization may be
needed after translation at the ER. Or, the MSD may exist as a dimer and
monomer in the prefusion spike, which would support an asymmetric 6HB-
formation. Also, if more than one spike is required for fusion and infection, the
GXXXG motif may mediate dimerization of MSDs from one spike to another
during fusion.
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Appendix A. Unique water molecules per residue script
This script, written in tcl, finds the number and standard deviation of water
molecules that uniquely associate with each residue.
#Number of unique waters per residue
#mbaker
#added standard deviation
mol new WT1_nff.psf
mol addfile WT1_wrap_every10.dcd waitfor all
set nf [molinfo top get numframes]
set sel1 [atomselect top "water and same residue as within 4 of
protein"]
set sel2 [atomselect top protein]
set w [atomselect top water]
set seg [lsort -unique [$w get segname]]
$w delete
set outfile [open WT1_water_unique_std.dat w]
set wat {}
for {set j 0} {$j < 27} {incr j} {
lappend wat 0
}
for {set i 0} {$i < $nf} {incr i} {
$sel1 frame $i
$sel1 update
$sel2 frame $i
$sel2 update
set list2 {}
set cts [measure contacts 4 $sel1 $sel2]
set wlist [lindex $cts 0]
set plist [lindex $cts 1]
foreach w $wlist p $plist {
set sel [atomselect top "index $w" frame $i]
set selp [atomselect top "index $p" frame $i]
set d [measure bond "$w $p" frame $i]
lappend list2 [list [$sel get segname] [$sel get
resid] $d [$selp get resid]]
$sel delete
$selp delete
}
#use lsearch to separate based on segname
foreach s $seg {
set list3 [lsearch -index 0 -all -inline $list2 $s]
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set list4 [lsort -index 1 -integer -increasing
$list3]
set length [llength $list4]
set listb {}
if {$length > 0} {
set idx 0
while {$idx < $length} {
set low [lindex $list4 $idx 1]
lappend listb [lsort -index 1
-unique [lsort -index 2
-decreasing -real [lsearch -index
1 -all -inline $list4 $low]]]
set idx [expr [lindex [lsearch
-index 1 -all $list4 $low] end] +
1]
}
}
#count unique waters for each residue
for {set k 0} {$k < [llength $listb ]} {incr k} {
lset wat [expr [lindex $listb $k 0 3] -681]
[expr [lindex $wat [expr [lindex $listb
$k 0 3] -681]] +1]
}
}
puts "frame $i"
}
#average over all frames
set wat_avg {}
for {set m 0} {$m < 27} {incr m} {
lappend wat_avg [expr [lindex $wat $m]/$nf.]
}
#Recalculate with standard deviation
set wat {}
set std {}
for {set j 0} {$j < 27} {incr j} {
lappend wat 0
lappend std 0
}
for {set i 0} {$i < $nf} {incr i} {
$sel1 frame $i
$sel1 update
$sel2 frame $i
$sel2 update
set list2 {}
set wat_frame {}
for {set j 0} {$j < 27} {incr j} {
lappend wat_frame 0
}
132
set cts [measure contacts 4 $sel1 $sel2]
set wlist [lindex $cts 0]
set plist [lindex $cts 1]
foreach w $wlist p $plist {
set sel [atomselect top "index $w" frame $i]
set selp [atomselect top "index $p" frame $i]
set d [measure bond "$w $p" frame $i]
lappend list2 [list [$sel get segname] [$sel get
resid] $d [$selp get resid]]
$sel delete
$selp delete
}
#use lsearch to separate based on segname
foreach s $seg {
set list3 [lsearch -index 0 -all -inline $list2 $s]
set list4 [lsort -index 1 -integer -increasing
$list3]
set length [llength $list4]
set listb {}
if {$length > 0} {
set idx 0
while {$idx < $length} {
set low [lindex $list4 $idx 1]
lappend listb [lsort -index 1
-unique [lsort -index 2
-decreasing -real [lsearch -index
1 -all -inline $list4 $low]]]
set idx [expr [lindex [lsearch
-index 1 -all $list4 $low] end] +
1]
}
}
#count unique waters for each residue
for {set k 0} {$k < [llength $listb ]} {incr k} {
lset wat [expr [lindex $listb $k 0 3] -681]
[expr [lindex $wat [expr [lindex $listb
$k 0 3] -681]] +1]
lset wat_frame [expr [lindex $listb $k 0 3]
-681] [expr [lindex $wat_frame [expr [
lindex $listb $k 0 3] -681]] +1]
}
}
#Add to std for this frame
for {set m 0} {$m < 27} {incr m} {
lset std $m [expr [lindex $std $m] + ([lindex
$wat_avg $m]-[lindex $wat_frame $m])*([lindex
$wat_avg $m]-[lindex $wat_frame $m])]
}
puts "std frame $i"
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}
#print to outfile
for {set m 0} {$m < 27} {incr m} {
puts $outfile "[expr $m + 681] [lindex $wat_avg $m] [expr
sqrt([lindex $std $m]/$nf.)]"
}
close $outfile
exit
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Appendix B. Trimer enumeration script
This script in tcl enumerates the trimer structures from Aim III and saves them
in the pdb and dcd format.
# 7/19/11
# mbaker
set j 0
set cosang {-45 -42.3 -39.4 -36.4 -33.1 -29.6 -25.5 -20.8 -14.6 0 14
.6 20.8 25.5 29.6 33.1 36.4 39.4 42.3 45}
for {set i 0} {$i < 360} {incr i 10} {
foreach t1 $cosang {
for {set t2 -45} {$t2 < 50} {incr t2 5} {
for {set L 5} {$L < 26} {incr L 1} {
mol delete all
mol load psf final.psf pdb final.pdb
set sel1 [atomselect top "segname P1"]
set sel2 [atomselect top "segname P2"]
set sel3 [atomselect top "segname P3"]
## Interior Rotation: alpha, 10 to 360 in 10
deg increments around z-axis
set cent1 [measure center $sel1]
$sel1 move [trans origin $cent1 axis z $i]
set cent2 [measure center $sel2]
$sel2 move [trans origin $cent2 axis z $i]
set cent3 [measure center $sel3]
$sel3 move [trans origin $cent3 axis z $i]
## Tilt #1 -- beta, around x-axis
set cent1 [measure center $sel1]
set cent2 [measure center $sel2]
set cent3 [measure center $sel3]
$sel1 move [trans origin $cent1 axis {1 0 0}
$t1]
$sel2 move [trans origin $cent2 axis {1 0 0}
$t1]
$sel3 move [trans origin $cent3 axis {1 0 0}
$t1]
## Tilt #2 -- gamma, around z-axis
set cent1 [measure center $sel1]
set cent2 [measure center $sel2]
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set cent3 [measure center $sel3]
$sel1 move [trans origin $cent1 axis {0 0 1}
$t2]
$sel2 move [trans origin $cent2 axis {0 0 1}
$t2]
$sel3 move [trans origin $cent3 axis {0 0 1}
$t2]
## Axisymmetric Rotation
set cent [measure center $sel1]
$sel1 move [trans origin $cent axis z 360]
set cent [measure center $sel2]
$sel2 move [trans origin $cent axis z 120]
set cent [measure center $sel3]
$sel3 move [trans origin $cent axis z 240]
## Translation
$sel1 move [transoffset [list 0 -$L 0] ]
$sel2 move [transoffset [list [expr $L*cos(
.523599)] [expr $L*sin(.523599)] 0] ]
$sel3 move [transoffset [list [expr -$L*cos(
.523599)] [expr $L*sin(.523599)] 0] ]
## Write pdb
set sel [atomselect top all]
set track [concat $i.$t1.$t2.$L]
set var [format %06i $j]
$sel writepdb ${var}.pdb
puts "$var = $track"
set j [expr $j + 1]
}
}
}
}
mol delete all
for {set j 0} {$j < 272916} {incr j 1} {
set var [format %06i $j]
animate read pdb ${var}.pdb
}
animate write dcd set_trimers.dcd waitfor all top
exit
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Appendix C. Anton configuration parameters
Below are the configuration parameters for WT1, WT2, and WT3 from Aim II
used with Anton software version 2.6.4.
anton = {
chem = {
Escale = "1000."
FmaxSeparation = "2.0"
Fscale = "3000."
Tempmax = "350"
maxBondLength = "4.0"
max_strain = "0.1"
r_over_sigmamin = "0.60"
rmin = "0.9"
}
run_options = {
cm_port = "37907"
ganglia_addr = " log.anton.desres.deshaw.com"
jobid = "105239"
jobstep_id = "105239"
}
tune = {
BumpyBoxDelta = "1.535"
BumpyN = "8"
DistNumSubboxesX = "1"
DistNumSubboxesY = "1"
DistNumSubboxesZ = "2"
NumSubboxesX = "1"
NumSubboxesY = "2"
NumSubboxesZ = "2"
PacketsPerSubboxPerCore = "5"
check_overflow = "true"
checkpoint = {
first = "0"
interval = "1200"
on_last_timestep = "true"
outdir = "checkpoint.atr"
}
go_verbosity = "0"
jobstep_wallclock = "30"
last_time = "Inf"
machine_size = ["8" "8" "8"]
optional = {
AllowDRAMMode = "false"
BondChunksPerNode = "1"
}
regenerateBondProgram = "true"
trajectory = {
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first = "0"
format = "dtr"
interval = "240"
outdir = "run.atr"
periodicfix = "true"
write_velocity = "true"
}
}
}
boot = {
file = "WT_final.dms"
}
force = {
nonbonded = {
electrostatic = {
type = "ewald"
}
far = {
n_k = ["64" "64" "64"]
r_spread = "6.654"
sigma = "1.9987426757812492"
sigma_s = "1 .3295978613281245"
type = "gse"
}
r_cut = "9.0"
r_lazy = "9.5"
}
}
global_cell = {
r_clone = "7.008"
}
integrator = {
Multigrator = {
barostat = {
MTK = {
T_ref = "310"
tau = "0.0416667"
thermostat = {
NoseHoover = {
chain = {
mts = "1"
tau = ["0.0416667" "0.0416667" "0
.0416667"]
}
}
type = "NoseHoover"
}
}
interval = "240"
type = "MTK"
}
nve = {
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PLS = {
number_of_stages = "3"
}
type = "Verlet"
}
thermostat = {
NoseHoover = {
chains = [{
mts = "1"
tau = ["0.0416667" "0.0416667" "0.0416667"]
}]
use_molecular_ke = "true"
}
interval = "24"
type = "NoseHoover"
}
}
dt = "0.0020"
pressure = {
isotropy = "semi_isotropic"
max_margin_contraction = "0.9"
p_ref = "1"
}
remove_com_motion = "false"
respa = {
bonded_interval = "1"
nonbonded_far_interval = "3"
nonbonded_near_interval = "1"
}
temperature = [{
T_ref = "310"
}]
type = "Multigrator"
}
Below are the configuration parameters for MPER-MSD from Aim III used with
Anton software version 2.12.4.
anton = {
chem = {
Escale = "3000 .0000"
FmaxSeparation = "2.0"
Fscale = "4000 .0000"
Tempmax = "350"
average_dispersion_type = "manual"
maxBondLength = "4.0"
max_strain = "0.1"
r_over_sigmamin = "0.60"
rmin = "0.9"
}
run_options = {
cm_port = "57602"
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ganglia_addr = " log.anton.desres.deshaw.com"
jobid = "263210"
jobstep_id = "263210"
}
tune = {
BumpyBoxDelta = "1.293"
BumpyN = "4"
DistNumSubboxesX = "2"
DistNumSubboxesY = "1"
DistNumSubboxesZ = "2"
NumSubboxesX = "2"
NumSubboxesY = "1"
NumSubboxesZ = "2"
PacketsPerSubboxPerCore = "7"
check_overflow = "true"
checkpoint = {
first = "0"
interval = "12000"
on_last_timestep = "true"
outdir = "checkpoint.atr"
}
go_verbosity = "0"
jobstep_wallclock = "30"
last_time = "Inf"
machine_size = ["8" "8" "8"]
optional = {
BondChunksPerNode = "1"
}
regenerateBondProgram = "true"
trajectory = {
first = "0"
format = "dtr"
interval = "240"
outdir = "run.dtr"
periodicfix = "true"
}
}
}
boot = {
file = "trimer_para.dms"
}
force = {
nonbonded = {
average_dispersion = "0"
electrostatic = {
type = "ewald"
}
far = {
n_k = ["64" "64" "64"]
r_spread = "7.457"
sigma = "2.3823378906249997"
sigma_s = "1 .5761651171874997"
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type = "gse"
}
r_cut = "10.78"
r_lazy = "11.28"
}
}
global_cell = {
r_clone = "7.811"
}
integrator = {
Multigrator = {
barostat = {
MTK = {
T_ref = "310.00"
tau = "0.0416667"
thermostat = {
NoseHoover = {
chain = {
mts = "1"
tau = ["0.0416667" "0.0416667" "0
.0416667"]
}
}
type = "NoseHoover"
}
}
interval = "240"
type = "MTK"
}
nve = {
PLS = {
number_of_stages = "3"
}
type = "Verlet"
}
thermostat = {
Langevin = {
seed = "0x98765432"
tau = "0.3"
use_molecular_ke = "false"
}
interval = "24"
type = "Langevin"
}
}
dt = "0.0020"
pressure = {
isotropy = "semi_isotropic"
max_margin_contraction = "0.9"
p_ref = "1"
tension_ref = ["0" "0" "0" "0" "0" "0" "0" "0" "0"]
}
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remove_com_motion = "true"
respa = {
bonded_interval = "1"
nonbonded_far_interval = "3"
nonbonded_near_interval = "1"
}
temperature = [{
T_ref = "310"
}]
type = "Multigrator"
}
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